<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">IJOC</journal-id><journal-title-group><journal-title>International Journal of Organic Chemistry</journal-title></journal-title-group><issn pub-type="epub">2161-4687</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ijoc.2015.52010</article-id><article-id pub-id-type="publisher-id">IJOC-57021</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject><subject> Chemistry&amp;Materials Science</subject></subj-group></article-categories><title-group><article-title>
 
 
  Synthesis, Reactions and Antimicrobial Activity of Some New 3-Substituted Indole Derivatives
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>smaa</surname><given-names>S. Salman</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Naema</surname><given-names>A. Mahmoud</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Anhar</surname><given-names>Abdel-Aziem</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mona</surname><given-names>A. Mohamed</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Doaa</surname><given-names>M. Elsisi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Biochemistry Division, Faculty of Science, Al-Azhar University, Girls’ Branch, Nasr City, Cairo, Egypt</addr-line></aff><aff id="aff1"><addr-line>Department of Chemistry, Faculty of Science, Al-Azhar University, Girls’ Branch, Nasr City, Cairo, Egypt</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>salman_2007_ok@yahoo.com(SSS)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>25</day><month>05</month><year>2015</year></pub-date><volume>05</volume><issue>02</issue><fpage>81</fpage><lpage>99</lpage><history><date date-type="received"><day>7</day>	<month>April</month>	<year>2015</year></date><date date-type="rev-recd"><day>accepted</day>	<month>7</month>	<year>June</year>	</date><date date-type="accepted"><day>10</day>	<month>June</month>	<year>2015</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Reaction of indole-3-carboxaldehydes 4 with hydrazine derivatives and different substituted acid hydrazides afforded the corresponding hydrazine derivatives 5a-c and acid hydrazide derivatives 7-11 respectively. Condensation of indole-3-carboxaldehydes 4 with phenacyl bromide and thiourea gives 1,3-thiazol-2-amine derivative 18. On the other hand, reaction 4 with 3-acetylchromene-2-one afforded chalcone derivative 19. Compound 4 undergoing Knoevenagel condensation with cyanoacetamide, ethyl cyanoacetate, benzimidazol-2-ylacetonitrile, rhodanine-3-acetic acid, 2,3-dihydropyrimidin-4-one derivative and 2,4-dihydropyrazol-3-one afforded the compounds 20a,b, 22, 23, 27 and 28 respectively. The structure of the newly synthesized compounds has been confirmed by elemental analysis and spectra data. The antimicrobial activities of the some newly synthesized compounds were measured and showed that most of them have high activities
 
</p></abstract><kwd-group><kwd>Indole-3-Carboxaldehyde</kwd><kwd> Acid Hydrazide</kwd><kwd> 1</kwd><kwd>3-Thiazole</kwd><kwd> Pyrimidine</kwd><kwd> Antimicrobial</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>In the recent past, bacterial infections have increased at an alarming rate causing deadly diseases and wide- spread epidemics in humans. All types of bacterial diseases have taken a high toll on humanity. The resistance of antibiotics to control emerging and pre-emerging bacterial pathogens focused the medicinal chemists to search potential new antimicrobial agents to cure microbial infections effectively [<xref ref-type="bibr" rid="scirp.57021-ref1">1</xref>] .</p><p>Heterocyclic compounds containing nitrogen have been described for their biological activity against various micro-organisms. The indole unit is the key building block for a variety of compounds which have crucial roles in the functions of biologically important molecules. Many indole alkaloids are recognized as one of the rapidly growing groups of marine invertebrate metabolites for their broad spectrum of biological properties [<xref ref-type="bibr" rid="scirp.57021-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.57021-ref3">3</xref>] . For example, five new indole alkaloids, meridianins A-E have been isolated from the tunicate Aplidium meridianum, which showed cytotoxicity toward murine tumor cell lines [<xref ref-type="bibr" rid="scirp.57021-ref4">4</xref>] .</p><p>Introduction of different groups to the modified indole structure can produce a series of compounds with multiple activities. Various 3-substituted indoles had been used as starting materials for the synthesis of a number of alkaloids, agrochemicals, pharmaceuticals and perfumes. Also 3-substituted indole derivatives possess various types of broad spectrum’s biological activities such as antimicrobial, antitumor, hypoglycemic, anti-inflamma- tory, analgesic and antipyretic activities [<xref ref-type="bibr" rid="scirp.57021-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.57021-ref6">6</xref>] . Moreover the substitution at the 3-position of the indole ring can take place by connecting an additional heterocyclic ring, such as imidazole (topsentins, nortopsentins) [<xref ref-type="bibr" rid="scirp.57021-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.57021-ref8">8</xref>] , dihydroimidazole (discodermindole) [<xref ref-type="bibr" rid="scirp.57021-ref9">9</xref>] , oxazole (pimprinols A-C, almazole C) [<xref ref-type="bibr" rid="scirp.57021-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.57021-ref11">11</xref>] , thiazole (bacillamide A) [<xref ref-type="bibr" rid="scirp.57021-ref12">12</xref>] , quinazoline (tremorgens) [<xref ref-type="bibr" rid="scirp.57021-ref13">13</xref>] , and pyrimidine [<xref ref-type="bibr" rid="scirp.57021-ref14">14</xref>] . Therefore, 3-substituted indoles still represent a significant synthetic challenge. In view of the important biological properties of the indole ring, we planned to synthesize a new series of 3-substituted indole derivatives bearing side chains with different structures; as such derivatives could possess interesting and useful antimicrobial activity.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Experimental</title><p>Melting points were measured on a Gallenkamp apparatus and are uncorrected. IR spectra were recorded on Shimadzu FT-IR 8101 PC infrared spectrophotometer (υ<sub>max</sub> in cm<sup>−1</sup>). The 1H NMR and <sup>13</sup>C NMR spectra were determined in DMSO-d6 at 300 MHz on a Varian Mercury VX 300 NMR spectrometer using TMS as an internal standard. Mass spectra were measured on a GCMS-QP1000 EX spectrometer at 70 Ev. Elemental analyses were carried out at the Microanalytical Center of Cairo University. Spectral data of the synthesized compounds were given in <xref ref-type="table" rid="table1">Table 1</xref>.</p><sec id="s2_1_1"><title>2.1.1. General Procedure for the Synthesis of 2-Substituted-Indole (3a-d)</title><p>Synthesis of 2-substituted-1H-indole 3a-d was carried out by the procedure of Fischer indole synthesis. Phenylhydrazone derivatives 2a-d were prepared by warming a mixture of compounds 1a-d (0.04 mol) and phenyl hydrazine (0.072 ml, 0.04 mol) with 60 ml of ethanol and few drops of glacial acetic acid. The resulting reaction mixture was allowed to stirring for about 2 h. The reaction mixture was then poured into ice water (50 ml) where upon the crude compound was precipitated. The residue obtained after filtration was washed with water and used in second step. A mixture of 2a-d (0.01 mol) and polyphosphoric acid (20 ml) was refluxed for 6 h. After the completion of the reaction, it was filtered and filtrate was poured into ice cooled water. The solid obtained was filtered and recrystallized from the ethanol to give 3a-d.</p><p>2-(4-Methylphenyl)-1H-indole 3a</p><p>Yellow crystals. Yield: (1.24 g, 60%); m.p.: 220-221˚C. Anal. calcd. for C<sub>15</sub> H<sub>13</sub> N(207.27): C, 86.92; H, 6.32; N, 6.76. Found: C, 86.62; H, 6.12; N, 6.56.</p><p>4-(1H-Indol-2-yl)aniline 3b</p><p>White crystals. Yield (1.37 g, 66%); m.p.: 250-252˚C. Anal. calcd. for C<sub>14</sub> H<sub>12</sub> N<sub>2</sub> (208.25):C, 80.74; H, 5.81; N,13.45.Found: C, 80.54; H, 5.61; N, 13.35.</p><p>2-(4-Bromophenyl)-1H-indole 3c</p><p>Yellow crystals. Yield (1.63, 60%); m.p.: 220-222˚C. Anal. calcd. for C<sub>14</sub> H<sub>10</sub> Br N (272.14): C, 61.79; H, 3.70; Br, 29.36; N, 5.15. Found: C, 61.59; H, 3.50; Br, 29.16; N, 5.00.</p><p>3-(1H-Indol-2-yl)-2H-chromen-2-one 3d</p><p>Dark brown crystals. Yield (1. 57, 60%; m.p.: 240-242˚C (DMF). Anal. calcd. for C<sub>17</sub> H<sub>11</sub> NO<sub>2</sub> (261.27): C, 78.15; H, 4.24; N, 5.36. Found: C, 78.00; H, 4.04; N, 5.06.</p></sec><sec id="s2_1_2"><title>2.1.2. 2-(4-Bromophenyl)-1H-indole-3-carboxaldehyde 4</title><p>Phosphorous oxychloride (21.47 ml, 0.14 mol) was added drop wise to N,N<sup>/</sup>-dimethylformamide (DMF) (10.23 ml, 0.14 mol) under cooling with an ice bath and the reaction mixture was stirred for 2 h. to prepare the Vilsmeier reagent. Then compound 3c (19.59 g, 0.072 mol) in DMF (20 ml) was added drop wise into the Vilsmeier</p><table-wrap-group id="1"><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Spectral data of the newly prepared compounds 3-31</title></caption><table-wrap id="1_1"><table><tbody><thead><tr><th align="center" valign="middle" >Compd. No.</th><th align="center" valign="middle" >Spectral Data</th></tr></thead><tr><td align="center" valign="middle" >3a</td><td align="center" valign="middle" >FT-IR (KBr υ<sub>max</sub> cm<sup>−1</sup>): 3436 (NH), 3042, 2911, 2856 (CH), 1610 (C=N). 1H NMR (DMSO-d6) δ ppm: 2.50 (s, 3H, CH<sub>3</sub>), 6.82 (s, 1H, H-3 indole), 6.97 - 7.07 (m, 4H. Ar-H), 7.25 (d, 1H, indole proton), 7.36 - 7.73 (m, 2H, indole proton), 7.76 (d, 1H, indole proton), 11.45 (s, 1H, NH). MS. m/z (%): 207 (M<sup>+</sup>, 100), 192 (3.12), 180 (3.18), 116 (1.99), 89 (20.56), 69 (29.66).</td></tr><tr><td align="center" valign="middle" >3b</td><td align="center" valign="middle" >FT-IR (KBr υ<sub>max</sub> cm<sup>−1</sup>): 3366, 3260, 3180 (NH<sub>2</sub>, NH), 2915, 2855 (CH), 1599 (C=N). 1H NMR (DMSO-d6) δ ppm: 6.54 (s, 2H, NH<sub>2</sub>), 6.70 - 7.21 (m, 5H, Ar-H and H-3 indole), 7.50 (d, 1H, indole proton), 7.71 - 7.82 (m, 2H, indole proton), 8.19 (d, 1H, indole proton), 9.13 (s, 1H, NH).</td></tr><tr><td align="center" valign="middle" >3c</td><td align="center" valign="middle" >FT-IR (KBr υ<sub>max</sub>, cm<sup>−1</sup>): 3182 (NH), 3057, 2977, 2867 (CH). 1H NMR (DMSO-d6) δ ppm: 6.46 (s, 1H, H-3 indole), 7.22 - 7.32 (m, 4H, Ar-H), 7.47 (d, 1H, indole proton), 8.21 (d, 1H, indole proton), 12.43 (s, 1H, NH).</td></tr><tr><td align="center" valign="middle" >3d</td><td align="center" valign="middle" >FT-IR (KBr υ<sub>max</sub> cm<sup>−1</sup>): 3426 (NH), 3037, 2917, 2851 (CH), 1671 (C=O). 1H NMR (DMSO-d6) δ ppm: 5.46 (s, 1H, H-3 indole proton), 7.14 - 7.95 (m, 9H, Ar-H and indole proton), 8.20 (s, 1H, NH). MS. m/z (%): 261 (M<sup>+</sup>, 18.48), 193 (2.80), 145 (18.01), 116 (13.51), 69 (100).</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >FT-IR (KBr, υ<sub>max</sub> cm <sup>−1</sup>): 3181 (NH); 3063, 2978, 2868, 2713 (CH), 1672 (C=O), 1578 (C=N). 1H NMR (DMSO-d6) δ ppm: 7.22 - 7.32 (m, 4H, Ar-H), 7.50 (d, 1H, indole proton), 7.72 -7.82 (m, 2H, indole proton), 8.19 (d, 1H, indole proton), 9.95 (s, 1H, CHO), 12.40 (s, 1H, NH exchanged by D<sub>2</sub>O). MS. m/z (%): 300 (M<sup>+</sup>, ‏,100 %), 220 (47), 219 (90.8), 190 (53), 165 (19.1), 143 (15.7).</td></tr><tr><td align="center" valign="middle" >5a</td><td align="center" valign="middle" >FT-IR (KBr, υ<sub>max</sub> cm<sup>−1</sup>): 3421, 3385, 3129 (NH<sub>2</sub>, NH), 3048, 2965, 2860 (CH), 1607 (C=N), 1578 (C=C). 1H NMR (DMSO-d6) δ ppm: 7.05 - 7.29 (m, 4H, Ar- H), 7.46 (d, 1H, indole proton), 7.66 - 7.68 (m, 2H, indole proton), 8.42 (d, 1H, indole proton), 8.91 (s, 1H, =CH), 12.06 (s, 1H, NH exchanged by D<sub>2</sub>O), 4.34 (s, 2H, NH<sub>2</sub> exchanged by D<sub>2</sub>O).</td></tr><tr><td align="center" valign="middle" >5b</td><td align="center" valign="middle" >FT-IR (KBr, υ<sub>max</sub> cm<sup>−1</sup>): 3249 (NH), 3056, 2921, 2855 (CH), 1592 (C=N), 1532 (C=C). 1H NMR (DMSO-d6) δ ppm: 7.04 - 8.10 (m, 13H, Ar-H), 6.75 (s, 1H, =CH), 8.22 (s, 1H, NH exchanged by D<sub>2</sub>O), 4.33 (s, 1H, NH exchanged by D<sub>2</sub>O). MS. m/z (%): 391(M<sup>+</sup> +1, 26.6), 389 (M<sup>+</sup> - 1, 30.5), 233 (2.1), 298 (100), 284 (12.3), 271 (46.9), 190 (60.5).</td></tr><tr><td align="center" valign="middle" >5c</td><td align="center" valign="middle" >FT-IR (KBr, υ<sub>max</sub> cm<sup>−1</sup>): 3181 (NH), 3050, 2921 (CH), 1600 (C=N), 1573 (C=C). 1H NMR (DMSO-d6) δ ppm: 7.06 - 7.24 (m, 4H, Ar-H), 7.26 - 7.31 (m, 2H, benothiazole proton), 7.38 (d, 1H, benothiazole proton), 7.47 (d, 1H, indole proton),7.61-7.64 (m, 2H, indole proton), 7.73 (d, 1H, benothiazole proton), 8.36 (d, 1H, indole proton), 8.42 (s, 1H, =CH), 7.95 (s, 1H, NH exchanged by D<sub>2</sub>O), 11.82 (s, 1H, NH exchanged by D<sub>2</sub>O). MS. m/z (%): 447 (M<sup>+</sup>, 11.24), 313 (13.70), 296 (10.33), 204 (15.63), 150 (100).</td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >FT-IR (KBr, υ<sub>max</sub> cm<sup>−1</sup>): 3207(NH), 3054, 3008, 2932, 2862 (CH), 1652 (C=O), 1611 (C=N), 1573 (C=C). 1H NMR (DMSO-d6) δ ppm: 7.14 - 8.80 (m, 14H, -Ar-H), 4.89 (s, 2H, CH<sub>2</sub>), 8.90 (s, 1H, =CH), 11.92 (s, 1H, NH exchanged by D<sub>2</sub>O), 12.05 (s, 1H, NH exchanged by D<sub>2</sub>O).</td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >FT-IR (KBr, υ<sub>max</sub> cm <sup>−1</sup>): 3389, 3165 (NH), 3054, 2962, 2848 (CH), 1654 (C=O), 1604 (C=N). 1H NMR (DMSO-d6) δ ppm: 3.78 (s, 2H,CH<sub>2</sub>), 7.16 - 7.28 (m, 5H, Ar-H and H-2 indole), 7.45 (d, 2H, indole proton), 7.56 - 7.89 (m, 4H, indole proton), 8.41 (d, 2H, indole proton), 8.90 (s, 1H, =CH), 4.31 (s, 1H, NH exchanged by D<sub>2</sub>O), 12.03 (s, 2H, NH exchanged by D<sub>2</sub>O). MS. m/z (%): 471 (M<sup>+</sup>, 0.94), 211 (4.96), 203 (74.04), 177 (12.11), 159 (13.50), 136 (37.99), 91 (100).</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >FT-IR (KBr, υ<sub>max</sub> cm<sup>−1</sup>): 3419, 3379, 3273 (NH), 3051, 2918, 2856 (CH), 1658 (C=O), 1604 (C=N). 1H NMR (DMSO-d6) δ ppm: 1.95 - 2.03 (m, 2H, CH<sub>2</sub>), 2.20 (t, 2H,CH<sub>2</sub>), 2.71(t, 2H, CH<sub>2</sub>), 6.93 - 7.33 (m, 5H, Ar-H and H-2 indole), 7.42 (d, 2H, indole proton), 7.49 - 7.83 (m, 4H, indole proton), 8.12 (d,1H, indole proton), 8.35 (d, 1H, indole proton), 8.27 (s, 1H, =CH), 10.75 (s, 1H, NH exchanged by D<sub>2</sub>O), 10.99 (s, 1H, NH exchanged by D<sub>2</sub>O), 11.85 (s, 1H, NH exchanged by D<sub>2</sub>O).</td></tr><tr><td align="center" valign="middle" >10</td><td align="center" valign="middle" >FT-IR (KBr, υ<sub>max</sub> cm<sup>−1</sup>): 3426, 3168 (NH), 3098, 3048, 2953, 2849 (CH), 1648 (C=O), 1608 (C=N). 1H NMR (DMSO-d6) δ ppm: 7.17 - 7.29 (m, 5H, Ar-H and H-3 benzofuran), 7.46 (d, 2H, indol and benzofuran),7.65 - 7.85 (m, 4H, indole and benzofuran), 8.42 (d, 2H, indole and benzofuran), 8.90 (s, 1H, =CH), 7.95 (s, 1H, NH exchanged by D<sub>2</sub>O),12.04 (s, 1H, NH exchanged by D<sub>2</sub>O). MS. m/z (%): 458 (M<sup>+</sup>, 0.10), 313 (0.11), 296 (5.76), 52 (66.65), 204 (63.53), 133 (43.88), 91 (100).</td></tr><tr><td align="center" valign="middle" >11</td><td align="center" valign="middle" >FT-IR (KBr, υ<sub>max</sub> cm<sup>−1</sup>): 3394, 3171 (NH), 3045, 2961, 2918 (CH), 1650 (C=O), 1604 (C=N), 2205 (CN). 1H NMR (DMSO-d6) δ ppm: 4.33 (s, 2H, CH<sub>2</sub>), 7.16 - 7.28 (m,4H, Ar-H),7.44 (d, 1H, indole proton), 7.55 - 7.79 (m, 2H, indole proton), 8.11 (d, 1H, indole proton), 8.33 (s, 1H, N=CH), 11.33 (s, 1H, NH exchanged by D<sub>2</sub>O), 11.93 (s, 1H, NH exchanged by D<sub>2</sub>O). <sup>13</sup>C NMR (DMSO-d6) δ ppm: 24.39 (CH<sub>2</sub>), 116.19 (CN), 157.73 (C=N), 163.58 (CO), 107.75, 111.44, 111.66, 120.95, 122.14, 122.27, 123.13, 125.09, 130.07, 130.97, 131.16, 131.73, 131.89, 136.46.</td></tr></tbody></table></table-wrap><table-wrap id="1_2"><table><tbody><thead><tr><th align="center" valign="middle" >12</th><th align="center" valign="middle" >FT-IR (KBr, υ<sub>max</sub> cm<sup>−1</sup>): 3391, 3311, 3184 (NH), 3047, 2960, 2918 (CH), 1667 (C=O), 1603 (C=N), 2212 (CN). 1H NMR (DMSO-d6) δ ppm: 2.29 (s, 3H, CH<sub>3</sub>), 7.18 - 7.44 (m, 8H, Ar-H), 7.46 (d,1H, indole proton), 7.55 - 7.79 (m, 2H, indole proton), 8.19 (d, 1H, indole proton), 8.38 (s, 1H, = CH), 11.24 (s, 1H, NH exchanged by D<sub>2</sub>O), 11.33 (s, 1H, NH exchanged by D<sub>2</sub>O), 11.91 (s, 1H, NH exchanged by D<sub>2</sub>O). <sup>13</sup>C NMR (DMSO-d6) δ pm: 10.65 (CH<sub>3</sub>), 116.19 (CN), 155.22 (C=N), 159 (C=NNH), 111.41, 119.24, 122.18, 129.79, 130.07, 130.85, 131.04, 131.15, 131.24, 131.79, 133.31, 136.46, 136.46, 136.76.</th></tr></thead><tr><td align="center" valign="middle" >13a</td><td align="center" valign="middle" >FT-IR (KBr, υ<sub>max</sub> cm<sup>−1</sup>): 3335, 3126(NH), 3055, 2921 (CH), 1686 (C=O), 2204 (CN). 1H NMR (DMSO-d6) δ ppm: 7.19-8.57 (m, 19H, Ar-H and H-5 pyrazole ring), 8.96 (s, 1H, =CH), 9.21 (s, 1H, N=CH); 11.73 (s, 1H, NH exchanged by D<sub>2</sub>O), 12.04 (s, 1H, NH exchanged by D<sub>2</sub>O). MS, m/z (%), 611 (M<sup>+</sup>, 0.63), 392 (1.05), 379 (0.51), 358 (11.477), 327 (1.42), 217 (33.11), 77.02 (100).</td></tr><tr><td align="center" valign="middle" >13b</td><td align="center" valign="middle" >FT-IR (KBr,υ<sub>max</sub> cm <sup>−1</sup>): 3233, 3166 (NH), 3091, 2971 (CH), 1682 (C=O), 2208 (CN). 1H NMR (DMSO-d6) δ ppm: 7.22 - 8.39 (m, 12H, Ar-H), 8.68 (s, 1H, =CH), 8.88 (s, 1H, N=CH), 11.93 (s, 1H, NH exchanged by D<sub>2</sub>O), 12.42 (s, 1H, NH exchanged by D<sub>2</sub>O).</td></tr><tr><td align="center" valign="middle" >14</td><td align="center" valign="middle" >FT-IR (KBr, υ<sub>max</sub> cm<sup>−1</sup>): 3372, 3155 (NH), 3093, 2930, 2853 (CH), 1712 (C=O). 1H NMR (DMSO-d6) δ ppm: 5.17 (s, 1H, H-4 coumarin ring), 6.56 - 8.22 (m, 12 H, Ar-H), 8.72 (s, 1H, N=CH), 11.44 (s, 1H, NH exchanged by D<sub>2</sub>O), 11.56 (s, 1H, NH exchanged by D<sub>2</sub>O), 12.14 (s, 1H, NH exchanged by D<sub>2</sub>O). MS. m/z (%): 485(M<sup>+</sup>, 0.30), 470 (0.4), 457 (0.4), 442 (0.1), 417 (3.00), 271 (100), 191(61.6), 165 (77.9).</td></tr><tr><td align="center" valign="middle" >15</td><td align="center" valign="middle" >FT-IR (KBr, υ<sub>max</sub> cm<sup>−1</sup>): 3475, 3396, 3369, 3234, 3180 (2NH<sub>2,</sub> NH), 3059, 2934, 2838 (CH), 1721, 1670 (2 C=O), 2210 (CN). 1H NMR (DMSO-d6) δ ppm: 1.26 (t, 3H, CH<sub>2</sub>-CH<sub>3</sub>), 4.23 (q, 2H, CH<sub>2</sub>-CH<sub>3</sub>), 7.22 - 8.225 (m, 12 H, Ar-H and 2 NH<sub>2</sub>), 8.25 (s, 1H, N= CH), 12.91 (s, 1H, NH exchanged by D<sub>2</sub>O), 12.45 (s, 1H, NH exchanged by D<sub>2</sub>O).</td></tr><tr><td align="center" valign="middle" >16</td><td align="center" valign="middle" >FT-IR (KBr, υ<sub>max</sub> cm<sup>−1</sup>): 3395, 3269, 3164 (NH<sub>2</sub>, NH), 3049, 2974, 2866 (CH), 1665 (C=O), 1237 (C=S). 1H NMR (DMSO-d6) δ ppm: 7.16 - 8.48 (m, 15 H, Ar-H and NH<sub>2</sub>), 8.90(s, 1H, N=CH), 11.00 (s, 1H, NH exchanged by D<sub>2</sub>O), 12.43 (s, 1H, NH exchanged by D<sub>2</sub>O). <sup>13</sup>C NMR (DMSO-d6) δ ppm: 147.39 (C=N), 153 (C-NH<sub>2</sub>), 161.36 (CO), 183.91 (CS), 112.10, 113.61, 121.01, 122.38, 123.44, 125.7, 126.93, 130.7, 131.14, 131.87, 135.88, 136.51, 136.51, 141.72.</td></tr><tr><td align="center" valign="middle" >17</td><td align="center" valign="middle" >FT-IR (KBr, υ<sub>max,</sub> cm<sup>−1</sup>): 3129 (NH), 3091, 3052, 2947, 2860 (CH), 1681 (C=O), 1239 (C=S). 1H NMR (DMSO-d6) δ ppm: 2.25 (s, 3H, CH<sub>3</sub>), 7.05-7.81(m, 13 H, Ar-H), 8.22(s, 1H, =CH), 12.40 (s, 1H, NH exchanged by D<sub>2</sub>O).</td></tr><tr><td align="center" valign="middle" >18</td><td align="center" valign="middle" >FT-IR (KBr, υ<sub>max</sub> cm<sup>−1</sup>): 3269 (NH), 3090, 2970, 2869 (CH). 1H NMR (DMSO-d6) δ ppm: 6.85 (s, 1H, N=CH), 6.98-7.32 (m, 10 H, Ar-H and H-5 thiazole ring), 7.50 (d, 1H, indole proton), 7.65 - 7.82 (m, 2H, indole proton), 8.20 - 8.22 (d, 1H, indole proton), 12.43 (s, 1H, NH exchanged by D<sub>2</sub>O).</td></tr><tr><td align="center" valign="middle" >19</td><td align="center" valign="middle" >FT-IR (KBr, υ<sub>max</sub> cm<sup>−1</sup>): 3127 (NH), 3084, 2967, 2862 (CH), 1671, 1718 (2C=O). 1H NMR (DMSO-d6) δ ppm: 7.22 - 7.32 (m, 5 H, Ar-H and H-4 chromene), 7.44 (d, 2H, indole and chromene), 7.70 - 7.92 (m, 4H, indole and chromene), 7.93 - 7.97 (m, 2H, CH= CH), 8.00 - 8.22 (d, 2H, indole and chromene), 12.43 (s, 1H, NH exchanged by D<sub>2</sub>O).</td></tr><tr><td align="center" valign="middle" >20a</td><td align="center" valign="middle" >FT-IR (KBr, υ<sub>max</sub> cm<sup>−1</sup>): 3466, 3310, 3149 (NH<sub>2</sub>, NH), 3048, 2970, 2865 (CH), 1688 (C=O) and 2203 (CN). 1H NMR (DMSO-d6) δ ppm: 7.22 - 7.32 (m, 6 H, Ar-H and NH<sub>2</sub> proton), 7.47 - 7.83 (m, 3H, indole proton), 7.96 (d, 1H, indole proton), 8.22 (s, 1H, C=CH), 12.43 (s, 1H, NH exchanged by D<sub>2</sub>O).</td></tr><tr><td align="center" valign="middle" >20b</td><td align="center" valign="middle" >FT-IR (KBr, υ<sub>max</sub> cm<sup>−1</sup>): 3269 (NH), 3047, 2973, 2861 (CH), 2208 (CN), 1708 (C=O). 1H NMR (DMSO-d6) δ ppm: 1.03 (t, 3H, CH<sub>2</sub>CH<sub>3</sub>), 4.23 (q, 2H, CH<sub>2</sub> CH<sub>3</sub>), 7.29 - 7.35 (m, 4H, Ar-H), 7.56 - 7.86 (m, 3H, indole proton), 8.15 - 8.17 (d, 1H, indole proton), 8.25 (s, 1H, =CH); 4.34 (s, 1H, NH exchanged by D<sub>2</sub>O). MS. m/z (%): 395 (M<sup>+</sup>, 11.8), 321 (44.6), 242 (100), 215 (17.6), 214 (32.8).</td></tr><tr><td align="center" valign="middle" >21</td><td align="center" valign="middle" >FT-IR (KBr, υ<sub>max</sub> cm<sup>−1</sup>): 3303 (NH), 2203(CN), 3052, 2961, 2921, 2859 (CH), 1672 (C=O). 1H NMR (DMSO-d6) δ ppm: 4.20 (d, 1H, pyrazoline), 6.11 (d, 1H, pyrazoline), 6.97 - 7.00 (m, 4H, Ar-H), 7.02 - 7.87 (m, 3H, indole proton), 7.97 (d, IH, indole proton), 10.18 (s, 1H, NH exchanged by D<sub>2</sub>O), 11.41 (s, 1H, NH exchanged by D<sub>2</sub>O), 12.22 (s, 1H, NH exchanged by D<sub>2</sub>O).</td></tr><tr><td align="center" valign="middle" >22</td><td align="center" valign="middle" >FT-IR (KBr, υ<sub>max</sub> cm <sup>−1</sup>): 3384 (NH), 2212 (CN), 3054, 2957, 2852 (CH). 1H NMR (DMSO-d6) δ ppm: 7.21 - 7.32 (m, 4H, Ar-H), 7.57 - 7.95 (m, 8H, indole and benzimidazole proton), 8.31 (s, 1H, =CH), 12.57 (s, 1H, NH exchanged by D<sub>2</sub>O), 12.88 (s, 1H, NH exchanged by D<sub>2</sub>O).</td></tr><tr><td align="center" valign="middle" >23</td><td align="center" valign="middle" >FT-IR (KBr, υ<sub>max</sub> cm<sup>−1</sup>): 3355 (OH), 3179 (NH), 1623, 1707 (2C=O), 3095, 2974, 2865 (CH), 1242 (C=S). 1H NMR (DMSO-d6) δ ppm: 4.71 (s, 2H, CH<sub>2</sub>), 7.32 - 7.33 (m, 4H, Ar-H), 7.50 (d, 1H, indole proton), 7.66 - 7.79 (m, 2H, indole proton), 7.99 (s, 1H, CH=C), 8.19 (d, 1 H, indole proton), 12.43 (s, 1H, NH exchanged by D<sub>2</sub>O), 12.60 (s, 1H, OH exchanged by D<sub>2</sub>O). MS. m/z (%): 473 (M<sup>+</sup>, 1.4), 472 (M<sup>+</sup>-1, 4.1), 456 (0.2), 382 (0.7), 327 (15.6), 271 (100), 202 (4.9).</td></tr></tbody></table></table-wrap><table-wrap id="1_3"><table><tbody><thead><tr><th align="center" valign="middle" >26</th><th align="center" valign="middle" >FT-IR (KBr, υ<sub>max</sub> cm<sup>−1</sup>): 3249, 3154 (2 NH), 3026, 2814 (CH), 1689 (C=O), 1283 (C=S). 1H NMR (DMSO-d6) δ ppm: 3.21 (s, 2H, CH<sub>2</sub>), 6.79 - 7.79 (m, 6H, Ar-H and H-5 thiazole), 8.31 (s, 1H, NH exchanged by D<sub>2</sub>O), 9.34 (s, 1H, NH exchanged by D<sub>2</sub>O).</th></tr></thead><tr><td align="center" valign="middle" >27</td><td align="center" valign="middle" >FT-IR (KBr, υ<sub>max</sub> cm<sup>−1</sup>): 3232, 3260, 3176 (NH), 1668 (C=O), 3053, 2990, 2873 (CH), 1242(C=S). 1H NMR (DMSO-d6) δ ppm: 6.95 - 7.31 (m, 10 H, Ar-H and H-5 thiazole), 7.50 - 7.90 (m, 4H, indole proton), 9.96 (s, 1H, =CH), 12.18 (s, 1H, NH exchanged by D<sub>2</sub>O), 12.22 (s, 1H, NH exchanged by D<sub>2</sub>O), 12.40 (s, 1H, NH exchanged by D<sub>2</sub>O). <sup>13</sup>C NMR (DMSO-d6) δ ppm: 185.37 (CS), 168 (CO), 155.46 (C=C), 166 (C-NH), 108.01, 112.01, 112.01, 113.74, 121.01, 123.44, 125.70, 127.62, 128.93, 129.01, 130.21, 130.8, 134.46, 135.88, 144.51, 146.01, 148.01.</td></tr><tr><td align="center" valign="middle" >28</td><td align="center" valign="middle" >FT-IR (KBr, υ<sub>max</sub> cm <sup>−1</sup>): 3275 (NH), 1706 (C=O), 3037, 2988, 2817(CH). 1H NMR (DMSO-d6) δ ppm: 2.38 (s, 3H, CH<sub>3</sub>), 7.31 - 7.35(m, 9H, Ar-H), 7.36 - 7.53 (m, 4H, indole proton and =CH), 7.82 (d, 1H, indole proton), 12.40 (s, 1H, NH exchanged by D<sub>2</sub>O). <sup>13</sup>C NMR (DMSO-d6) δ ppm: 12.58 (CH<sub>3</sub>), 153(C=C), 160 (C=O), 108.82, 120.62, 120.74, 126.43, 126.63, 128.87, 129.07, 137.15, 140.16, 140.34. MS. m/z (%): 456 (M<sup>+</sup>, 1.9), 441 (0.3), 413 (0.4), 336 (3.4), 359 (48.1), 358 (100), 341 (62.3), 266 (20.3), 77 (92.7).</td></tr><tr><td align="center" valign="middle" >29a</td><td align="center" valign="middle" >FT-IR (KBr, υ<sub>max</sub>, cm<sup>−1</sup>): 3428, 3198 (NH), 3039, 2865(CH). 1H NMR (DMSO-d6) δ ppm: 2.26 (s, 3H, CH<sub>3</sub>), 6.93 - 7.18 (m, 9H, Ar-H), 7.29 - 7.82 (m, 4H, indole proton), 8.04 (s, 1H, NH exchanged by D<sub>2</sub>O), 11.56 (s, 1H, NH exchanged by D<sub>2</sub>O).</td></tr><tr><td align="center" valign="middle" >29b</td><td align="center" valign="middle" >FT-IR (KBr, υ<sub>max</sub> cm<sup>−1</sup>): 3209 (NH), 3048, 2917, 2863 (CH). 1H NMR (DMSO-d6) δ ppm: 2.21 (s, 3H, CH<sub>3</sub>), 6.93 - 7.32 (m, 14H, Ar-H), 7.37 - 7.82 (m, 4H, indole proton), 11.56 (s, 1H, NH exchanged by D<sub>2</sub>O). MS. m/z (%): 544 (M<sup>+</sup>, 3.3), 529 (2.3), 467 (22.9), 375 (15.41), 295 (6.2), 298 (100), 273 (71.8), 271 (17.2).</td></tr><tr><td align="center" valign="middle" >30</td><td align="center" valign="middle" >FT-IR (KBr,υ<sub>max</sub> cm<sup>−1</sup>): 3323, 3174 (NH), 3055, 2969, 2864 (CH), 1242 (C= S). 1H NMR (DMSO-d6) δ ppm: 2.24 (s, 3H, CH<sub>3</sub>), 2.28 (s, 3H, CH<sub>3</sub>), 7.11 - 7.35 (m, 13H, Ar-H), 7.37 - 7.86 (m, 4H, indole proton), 11.48 (s, 1H, NH exchanged by D<sub>2</sub> O), 12.00 (s, 1H, NH exchanged by D<sub>2</sub>O). MS. m/z (%): 617 (M<sup>+</sup>, 0.46), 587 (0.54), 522 (0.46), 467 (0.63), 414 (1.35), 330 (2.73), 252 (57.01), 125 (100).</td></tr><tr><td align="center" valign="middle" >31</td><td align="center" valign="middle" >FT-IR (KBr, υ<sub>max</sub>, cm<sup>−1</sup>): 3436 (NH), 3050, 2972, 2865 (CH), 1277 (C=S). 1H NMR (DMSO-d6) δ ppm: 2.28 (s, 3H, CH<sub>3</sub>), 7.93 - 8.31 (m, 17H, Ar-H), 11.54 (s, 1H, NH exchanged by D<sub>2</sub>O).</td></tr></tbody></table></table-wrap></table-wrap-group><p>reagent and continuous stirring and kept at room temperature for 2 h. The reaction mixture was allowed to stand overnight and was then refluxed for 2 h. under vigorous stirring. The mixture was then poured onto ice cold water and neutralized with dilute ammonia solution till the precipitation occurs. The formed precipitate was collected by filtration and recrystallized from ethanol to give 4 as yellow crystals. Yield (15.13 g, 70%, m.p.: 270-272˚C. Anal. calcd. for C<sub>15</sub> H<sub>10</sub> Br NO (300.15): C, 60.02; H, 3.36; Br, 26.62; N, 4.67. Found: C, 59.89; H, 3.16; Br, 26.42; N, 4.37.</p></sec><sec id="s2_1_3"><title>2.1.3. General Procedure for the Synthesis of 5a-c</title><p>An equimolecular mixture of 4 (3 g, 0.01 mol) and the hydrazine derivatives (0.5 ml, 0.01 mol) were refluxed in absolute ethanol (20 ml) in the presence of 2 - 3 drops of glacial acetic acid for the appropriate time. The reaction mixture was cooled to room temperature and poured into ice-cold water. The separated product was filtered, washed with cold water, dried and recrystallized from the appropriate solvent to give 5a-c.</p><p>1-[2-(4-Bromophenyl)-1H-indol-3-ylmethylene]hydrazine 5a</p><p>Compound 5a was prepared from hydrazine hydrate for 1 h. Orange crystals. Yield (2.48 g, 79%); m.p.: 338-340˚C (xylene). Anal. calcd. for C<sub>15</sub>H<sub>12</sub>Br N<sub>3</sub> (314.18): C, 57.34; H, 3.85; Br, 25.43; N, 13.37. Found: C, 57.24; H, 3.65; Br, 25.33; N, 13.17.</p><p>1-[ 2-(4-Bromophenyl)-1H-indol-3-ylmethylene]-2-phenyl-hydrazine 5b</p><p>Compound 5b was prepared from phenyl hydrazine for 4 h. Pale brown powder. Yield (2.5 g, 64%); m.p.: 115-117˚C (hexane). Anal.calcd. for C<sub>21</sub>H<sub>16</sub>BrN<sub>3</sub> (390.28): C, 64.63; H, 4.13; Br, 20.47; N, 10.77. Found: C, 64.43; H, 4.00; Br, 20.27; N, 10.57.</p><p>2-{2-[2-(4-Bromophenyl)-1H-indol-3-ylmethylene]hydrazine}-1,3-benzothiazole 5c</p><p>Compound 5c was prepared from 2-hydrazinyl-1,3-benzothiazole for 4 h. Pale yellow crystal. Yield (2.46 g, 55%); m.p.: 280-282˚C (ethanol/DMF). Anal. calcd. for C<sub>22</sub>H<sub>15</sub>BrN<sub>4</sub>S (447.35): C, 59.07; H, 3.38; Br, 17.86; N, 12.52; S, 7.17. Found: C, 58.98; H, 3.18; Br, 17.66; N, 12.40; S, 7.00.</p></sec><sec id="s2_1_4"><title>2.1.4. General Procedure for the Synthesis of 7-10</title><p>An equimolecular mixture of 4 (3 g,0.01 mol) and the acid hydrazide derivatives 6a-d (0.01 mol) was refluxed for 2 h. in absolute ethanol (20 ml) in the presence of 2 - 3 drops of glacial acetic acid. The reaction mixture was cooled to room temperature and poured into ice-cold water. The separated product was filtered, washed with cold water, dried and recrystallized from the appropriate solvent.</p><p>N'-[2-(4-Bromophenyl)-1H-indol-3-ylmethylene]-2-(quinolin-8-yloxy)acetohydrazide 7</p><p>Yellow crystals. Yield (3 g, 60%); m.p.: 290-292˚C (ethanol/DMF). Anal. calcd for C<sub>26</sub>H<sub>19</sub> BrN<sub>4</sub> O<sub>2</sub> (499.35): C, 62.54; H, 3.84; Br, 16.00; N, 11.22. Found: C, 62.24; H, 3.62; Br, 15.88; N, 11.02.</p><p>N'-(2-(4-Bromophenyl)-1H-indol-3-ylmethylene)-2-(1H-indol-3-yl)acetohydrazide 8</p><p>Red crystals. Yield (2.83 g, 60%); m.p.: 330-332˚C (ethanol). Anal. calcd for C<sub>25</sub>H<sub>19</sub>BrN<sub>4</sub>O (471.35): C, 63.70; H, 4.06; Br, 16.95; N, 11.89. Found: C, 63.40; H, 4.00; Br, 16.65; N, 11.59.</p><p>N'-[2-(4-Bromophenyl)-1H-indol-3-ylmethylene]-4-(1H-indol-3-yl)-butanehydrazide 9</p><p>Dark yellow powder. Yield (3.75 g, 75%); m.p.: 170-172˚C (xylene). Anal.calcd for C<sub>27</sub>H<sub>23</sub> BrN<sub>4</sub>O (499.40): C, 64.94; H, 4.64; Br, 16.00; N, 11.22. Found: C, 64.74; H, 4.34; Br, 15.88; N, 11.00.</p><p>N'-[ 2-(4-Bromophenyl)-1H-indol-3-ylmethylene]-benzofuran-2-carbohydrazide 10</p><p>Yellow crystals. Yield (2.75 g, 60%); m.p.: 320-322˚C (ethanol/DMF). Anal. calcd for C<sub>24</sub>H<sub>16</sub>BrN<sub>3</sub>O<sub>2</sub> (458.30): C, 62.90; H, 3.52; Br, 17.43; N, 9.17. Found: C, 62.70; H, 3.32; Br, 17.23; N, 9.00.</p></sec><sec id="s2_1_5"><title>2.1.5. N'-[2-(4-Bromophenyl)-1H-indol-3-ylmethylene]-2-cyanoacetohydrazide 11</title><p>An equimolecular mixture of 4 (3 g, 0.01 mol) and cyanoacetohydrazide (1.98 g, 0.02 mol) in absolute ethanol (30 ml) was heated under reflux for 2 h. The precipitate formed after cooling was filtered off, washed with cold ethanol, dried and recrystallized from DMF to give 11 as pale brown powder. Yield (3.24 g, 85%); m.p.: 290-292˚C. Anal. calcd for C<sub>18</sub>H<sub>13</sub>BrN<sub>4</sub>O (381.22): C, 56.71; H, 3.44; Br, 20.96; N, 14.70. Found: C, 56.41; H, 3.24; Br, 20.86; N, 14.50.</p></sec><sec id="s2_1_6"><title>2.1.6. N'-[2-(4-Bromophenyl)-1H-indol-3-ylmethylene]-2-cyano-2-[(4-methylphenyl)hydrazono]- acetohydrazide 12</title><p>To a cold solution of 11 (3.81 g, 0.01 mol) in ethanol (20 ml) containing sodium acetate (3.0 g) was added with continuous stirring 4-methylbenzene diazonium salt (0.01 mol) [prepared by adding sodium nitrite (1.38 g, 0.02 mol) in water (8 ml) to a cold solution of p-toluidine (1.07 g, 0.01 mol) in the appropriate amount of hydrochloric acid]. The reaction mixture was stirred for 2 h. and the formed solid was collected by filtration and recrystallized from ethanol to give 12 as orange crystals. Yield (3.5 g, 70%); m.p.: 240-242˚C. Anal. calcd for C<sub>25</sub>H<sub>19</sub> Br N<sub>6</sub>O (499.36): C, 60.13; H, 3.84; Br, 16.00; N, 16.83. Found: C, 60.00; H, 3.54; Br, 15.98; N, 16.75.</p></sec><sec id="s2_1_7"><title>2.1.7 General Procedure for the Synthesis of 13a,b and 14</title><p>Equimolecular mixture of 11 (3.81 g, 0.01 mol) and the selected aldehydes such as 1,3-diphenyl-1H-pyrazole-4- carboxaldehyde, p-nitrobenzaldehyde and salicyaldehyde (0.01 mol) in 1,4-dioxane (20 ml) containing piperidine (0.5 ml) was heated under reflux for 3 h. The reaction mixture was left to cool then poured onto ice/water containing few drops of hydrochloric acid and the formed solid product was collected by filtration and recrystallized from the appropriate solvent.</p><p>N'-[2-(4-Bromophenyl-1H-indol-3-ylmethylene]-2-cyano-3-(1,3-diphenyl-1H-pyrazol-4-yl) acrylohydrazide 13a</p><p>Yellow crystal. Yield (3.6 g, 55%); m.p.: 255-257˚C (ethanol/DMF). Anal. calcd for C<sub>34</sub>H<sub>23</sub>BrN<sub>6</sub>O (611.49): C, 66.78; H, 3.79; Br, 13.07; N, 13.74. Found: C, 66.48; H, 3.59; Br, 13.00; N, 13.55.</p><p>N'-[2-(4-Bromophenyl)-1H-indol-3-ylmethylene]-3-(4-nitrophenyl)-2-cyanoacrylohydrazide 13b</p><p>Yellow crystals. Yield (2.31 g, 45%); m.p.: 230-232˚C (ethanol). Anal.calcd for C<sub>25</sub>H<sub>16</sub>BrN<sub>5</sub>O<sub>3</sub> (514.33): C, 58.38; H, 3.14; Br, 15.54; N, 13.62. Found: C, 58.18; H, 3.00; Br, 15.34; N, 13.32.</p><p>N'-[2-(4-Bromophenyl)-1H-indol-3-ylmethylene]-2-imino-2H-chromene-3-carbohydrazide 14</p><p>Brown crystals. Yield (2.9 g, 60%); m.p.: 130-132˚C (hexane). Anal. calcd for C<sub>25</sub>H<sub>17</sub>BrN<sub>4</sub>O<sub>2</sub> (485.33): C, 61.87; H, 3.53; Br, 16.46; N, 11.54. Found: C, 61.57; H, 3.33; Br, 16.26; N, 11.34.</p></sec><sec id="s2_1_8"><title>2.1.8. General Procedure for the Synthesis of 15 and 16</title><p>To a solution of compound 11 (3.81 g, 0.01 mol) in absolute ethanol (50 ml) containing triethylamine (1 ml) either ethyl cyanoacetate (1.13 g, 0.01 mol) or phenylisothiocyanate (1.39 g, 0.01 mol) together with elemental sulfur (0.32 g, 0.01 mol) were added. Reaction mixture was heated under reflux for 8 h. then poured onto ice/water mixture and the formed solid product, in each case, was collected by filtration recrystallized from ethanol.</p><p>Ethyl 2,4-diamino-5-{[2-(2-(4-bromophenyl)-1H-indol-3-ylmethylene)hydrazino]-carbonyl}thiophene-3- carboxylate 15</p><p>Dark brown crystals. Yield (2.63 g, 50%); m.p.: 190-192˚C. Anal. calcd for C<sub>23</sub>H<sub>20</sub> BrN<sub>5</sub>O<sub>3</sub>S (526.40): C, 52.48; H, 3.83; Br,15.18; N, 13.30; S, 6.09. Found: C, 52.28; H, 3.53; Br, 15.00; N, 13.00; S, 6.00.</p><p>4-Amino-N'-[2-(4-bromophenyl)-1H-indol-3-ylmethylene]-3-phenyl-2-thioxo-2,3-dihydro-1,3-thiazole-5- carbohydrazide 16</p><p>Brown crystals. Yield (3.35 g, 61%); m.p.: 245-247˚C. Anal. calcd for C<sub>25</sub>H<sub>18</sub>Br N<sub>5</sub>OS<sub>2</sub> (548.47): C, 54.75; H, 3.31; Br, 14.57; N,12.77; S, 11.69. Found C, 54.55; H, 3.11; Br, 14.37; N, 12.57; S, 11.49.</p></sec><sec id="s2_1_9"><title>2.1.9. 6-[(2-(4-Bromophenyl)-1H-indol-3-ylmethylene)amino]-5-methyl-2-thioxo-3-phenyl-2,3- dihydro-1,3-thiazolo[4,5-d]pyrimidin-7(6H)-one 17</title><p>A solution of compound 16 (5.48 g, 0.01 mol) in a mixture of acetic acid (5 ml) and acetic anhydride (10 ml) was heated under reflux for 8 h. and then allowed to cool. The precipitate that formed was collected by filtration, dried and recrystallized from acetic acid to give compound 17 as yellow crystals; Yield (3.4 g, 60%); m.p.: 316-318˚C. Anal. Calcd. C<sub>27</sub> H<sub>18</sub> Br N<sub>5</sub> O S<sub>2</sub> (572.50): C, 56.64; H, 3.17; Br, 13.96; N, 12.23; S, 11.2. Found: C, 56.44; H, 3.07; Br, 13.66; N, 12.03; S, 11.00.</p></sec><sec id="s2_1_10"><title>2.1.10. N-[2-(4-Bromophenyl)-1H-indol-3-ylmethylene]-4-phenyl-1,3-thiazol-2-amine 18</title><p>A mixture of compound 4 (3 g, 0.01 mol), phenacyl bromide (0.01 mol) and thiourea (0.78 g, 0.01 mol) in absolute ethanol (30 ml) containing acetic acid (1 ml) were heated under reflux for 8 h. Reaction mixture poured in an ice cold water, the solid obtained was filtered, dried and recrystallized from ethanol to give 18 as brown powder. Yield (3.21 g, 70%); m.p.: 230-232˚C. Anal. calcd. for C<sub>24</sub>H<sub>16</sub>Br N<sub>3</sub>S (458.37): C, 62.89; H, 3.52; Br, 17.43; N, 9.17; S, 7.00. Found: C, 62.59; H, 3.22; Br, 17.23; N, 9.00; S, 6.81.</p></sec><sec id="s2_1_11"><title>2.1.11. 3-[3-(2-(4-Bromophenyl)-1H-indol-3-yl)prop-2-enoyl]-2H-chromen-2-on 19</title><p>A mixture of 4 (3 g, 0.01 mol), 3-acetyl-2H-chromen-2-one (1.88 g, 0.01 mol) in 20 ml absolute ethanol and 0.5 ml piperdine was refluxed for 30 min. The reaction mixture was left overnight at room temperature, the obtained solid was filtered off and recrystallized from ethanol to give 19 as yellow crystals. Yield (4.01 g, 64%); m.p.: 280-282˚C. Anal. calcd. for C<sub>26</sub>H<sub>16</sub>BrNO<sub>3</sub> (470.31): C, 66.40; H, 3.43; Br, 16.99; N, 2.98. Found: C, 66.30; H, 3.23; Br, 16.79; N, 2.78.</p></sec><sec id="s2_1_12"><title>2.1.12. General Procedure for the Synthesis of 20a,b and 22</title><p>To a solution of compound 4 (3 g, 0.01 mol) in 20 ml ethanol, the appropriate active methylene compounds such as cyanoacetamide, ethyl cyanoacetate and 1H-benzimidazol-2-ylacetonitrile (0.01 mol) and few drops of triethylamine was added. The reaction mixture was refluxed for 5 h. and then allowed to cool. The formed solid product was collected by filtration, washed with ethanol and recrystallized from the appropriate solvent.</p><p>3-[2-(4-Bromophenyl)-1H-indol-3-yl]-2-cyanoprop-2-enamide 20a</p><p>Yellow powder. Yield (2.38 g, 65%); m.p.: 210-212˚C (ethanol).Anal. calcd for C<sub>18</sub>H<sub>12</sub>BrN<sub>3</sub>O (366.21): C, 59.03; H, 3.30; Br, 21.82; N, 11.47. Found: C, 58.89; H, 3.00; Br, 21.52; N, 11.17.</p><p>Ethyl 3-[2-(4-bromophenyl)-1H-indol-3-yl]-2-cyanoprop-2-enoate 20b</p><p>Yellow powder. Yield (2.37 g, 60%); m.p.: 245-247˚C (ethanol\DMF). Anal. calcd. for C<sub>20</sub>H<sub>15</sub>BrN<sub>2</sub>O<sub>2</sub> (395.24): C, 60.78; H, 3.83; Br, 20.22; N, 7.09. Found: C, 60.48; H, 3.53; Br, 20.02; N, 7.00.</p><p>2-(1H-Benzimidazol-2-yl)-3-[2-(4-bromophenyl)-1H-indol-3-yl]acrylonitrile 22</p><p>Brown powder. Yield (2.64 g, 60%); m.p. 250-253˚C (ethanol\DMF). Anal. calcd. for C<sub>24</sub>H<sub>15</sub>BrN<sub>4 </sub>(439.30): C, 65.62; H, 3.44; Br, 18.19; N, 12.75. Found: C, 65.42; H, 3.24; Br, 18.09; N, 12.65.</p></sec><sec id="s2_1_13"><title>2.1.13. 3-[2-(4-Bromophenyl)-1H-indol-3-yl]-5-oxopyrazolidine-4-carbonitrile 21</title><p>A mixture of compound 20b (3.95 g, 0.01 mole) and hydrazine hydrate (0.75 ml, 0.015 mole) in ethanol (20 ml) was refluxed for 3 h, then poured into water. The resulting solid was collected and recrystallized from ethanol to give 21 as yellowish white crystals. Yield (1.91 g, 50%); m.p.: 198-200˚C. Anal. calcd for C<sub>18</sub>H<sub>13</sub>BrN<sub>4</sub>O (381.23): C, 56.71; H, 3.44; Br, 20.96; N, 14.70. Found: C, 56.51; H, 3.24; Br, 20.76; N, 14.50.</p></sec><sec id="s2_1_14"><title>2.1.14. {5-[2-(4-Bromophenyl)-1H-indol-3-ylmethylene]-4-oxo-2-thioxo-1,3-thiazolidin-3-yl}acetic acid 23</title><p>To a solution of rhodanine-3-acetic acid (1.91 g, 0.01 mol) and anhydrous sodium acetate (0.5 g) in glacial acetic acid was added the 1H-indole-3-carboxaldehyde 4 (3 g, 0.01 mol). The mixture was stirred under reflux for 6 h and then poured into ice-cold water. The precipitate was filtered, washed with water, dried and recrystallized from xylene to gives 23 as orange powder. Yield (3.08 g, 65%); m.p.: 223-225˚C. Anal. calcd. For C<sub>20</sub>H<sub>13</sub>BrN<sub>2</sub>O<sub>3</sub>S<sub>2</sub> (473.36): C, 50.75; H, 2.77; Br, 16.88; N, 5.92; S, 13.55. Found: C, 50.45; H, 2.57; Br, 16.58; N, 5.62; S, 13.25.</p></sec><sec id="s2_1_15"><title>2.1.15. Ethyl 3-Oxo-3-[(4-phenyl-1,3-thiazol-2-yl)amino]propanoate 25</title><p>A mixture of an equimolar amount of 4-phenyl-2-aminothiazole 24 (1.76 g, 0.01 mol) and diethylmalonate 1.6 g, 0.01 mol) was heated in an oil bath at 180˚C for 2 hours then left to cool. The product was collected and used in second step.</p></sec><sec id="s2_1_16"><title>2.1.16. 6-[(4-Phenyl-1,3-thiazol-2-yl)amino]-2-thioxo-2,3-dihydro-pyrimidin-4(5H)-one 26</title><p>A mixture of ester 25 (2.9 g, 0.01 mol) and thiourea (0.76 g, 0.01 mol) in ethanol (30 ml) containing sodium ethoxide was heated under reflux for 6 h. The reaction mixture was poured into cold water and the formed solid product was collected by filtration, washed, dried and recrystallized from ethanol to gives 26 as yellow crystals. Yield (3.8 g, 60%); m.p.:200-202˚C. Anal. calcd. for C<sub>13</sub> H<sub>10</sub> N<sub>4</sub> O S<sub>2</sub> (302.37): C, 51.64; H, 3.33; N, 18.53; S, 21.21. Found: C, 51.44; H, 3.13; N, 18.33; S, 21.01.</p></sec><sec id="s2_1_17"><title>2.1.17. 5-[2-(4-Bromophenyl)-1H-indol-3-ylmethylene]-6-[(4-phenyl-1,3-thiazol-2-yl)amino]- 2-thioxo-2,5-dihydropyrimidin-4(3H)-one 27</title><p>A mixture of pyrimidine derivative 26 (3 g, 0.01 mol) and 1H- indole-3-carboxaldehyde 4 (3 g, 0.01 mol) in ethanol (30 ml) was heated under reflux for 6 h., then left to cool. The solid product was collected by filtration and recrystallized from xylene to give 27 as green powder. Yield (2.34 g, 40%. m.p.: 208-210˚C. Anal. calcd. for C<sub>28</sub>H<sub>18</sub>BrN<sub>5</sub>OS<sub>2</sub> (584.50): C, 57.54; H, 3.10; Br, 13.67; N,11.98; S,10.97. Found: C, 57.34; H, 3.00; Br, 13.47; N, 11.68; S, 10.67.</p></sec><sec id="s2_1_18"><title>2.1.18. 4-[2-(4-Bromophenyl)-1H-indol-3-ylmethylene]-3-methyl-1-phenyl-1H-pyrazol-5(4H)-one 28</title><p>A mixture of 1H-pyrazol-5(4H)-one (1.74 g, 0.01 mol) and 1H- indole-3-carboxaldehyde 4 (3 g, 0.01 mol) in acetic acid in the presence of anhydrous sodium acetate was refluxed for 5 h. The reaction mixture was cooled to room temperature and poured into ice cold water. The solid separated out was filtered washed with water and recrystallized from (ethanol/DMF) to give 28 as orange crystals. Yield (3.01g, 66%); m.p.: 190-192˚C. Anal. calcd. for C<sub>25</sub>H<sub>18</sub>BrN<sub>3</sub>O (456.33): C, 65.80; H, 3.98; Br,17.51; N, 9.21. Found: C, 65.56; H, 3.68; Br, 17.31; N, 9.00.</p></sec><sec id="s2_1_19"><title>2.1.19. 2-(4-Bromophenyl)-3-(4-methyl-6-phenyl-2,6-dihydropyrazolo[3,4-c]pyrazol-3-yl)- 1H-indole 29a</title><p>A mixture of compound 28 (4.56 g, 0.01 ml) and hydrazine hydrate (0.5 ml, 0.01 ml) in ethanol in present of few drops of acetic acid was refluxed for 7 h. Reaction mixture was cooled at room temperature and poured in ice cold water. The solid separated was filtered, washed with water and recrystallized from ethanol to give 29a as yellow crystals. Yield (2.81 g, 60%); m.p.: 180-182˚C. Anal.calcd. for C<sub>25</sub>H<sub>18</sub>BrN<sub>5</sub> (468.34): C, 64.11; H, 3.87; Br, 17.06; N, 14.95. Found: C, 64.00; H, 3.57; Br, 16.89; N, 14.65.</p></sec><sec id="s2_1_20"><title>2.1.20. 2-(4-Bromophenyl)-3-(4-methyl-2,6-diphenyl-2,6-dihydropyrazolo[3,4-c]pyrazol-3-yl)- 1H-indole 29b</title><p>A mixture of compound 28 (4.56 g, 0.01 ml), phenyl hydrazine (1.08 ml, 0.01 mol), anhydrous sodium acetate (0.5 g) and acetic acid (20 ml) was refluxed for 7 h. Reaction mixture was cooled to room temperature and poured in ice cold water. The solid separated out was filtered, washed with water and recrystallized from ethanol to give 29b as yellow crystals. Yield (3.54 g, 65%); m.p.: 105-106˚C. Anal. calcd. for C<sub>31</sub>H<sub>22</sub>BrN<sub>5</sub> (544.44): C, 68.39; H, 4.07; Br, 14.68; N, 12.86. Found: C, 68.09; H, 4.00; Br, 14.48; N, 12.66.</p></sec><sec id="s2_1_21"><title>2.1.21. 3-(2-(4-Bromophenyl)-1H-indol-3-yl)-4-methyl-N-(4-methylphenyl)-6-phenyl-pyrazolo [3,4-c]-pyrazole-2(6H)-carbothioamide 30</title><p>A mixture of compound 28 (4.56 g, 0.01 mol) and N-(4-methylphenyl)thiosemicarbazide (1.81 g, 0.01 mol) was refluxed in ethanol in the presence of NaOH/H<sub>2</sub>O (10%, 5 ml) for 8 h. Reaction mixture was cooled to room temperature and poured in ice-cold water. The solid separated out was filtered, washed with water and recrystallized from ethanol to give 30 as yellow crystals, Yield (3.89 g, 63%); m.p.: 240-242˚C (ethanol). Anal. Calcd. for C<sub>33</sub>H<sub>25</sub>BrN<sub>6</sub>S (617.56): C, 64.18; H,4.08; Br,12.94; N, 13.61; S, 5.19. Found: C, 64.00; H, 4.00; Br, 12.70; N, 13.36; S, 5.09.</p></sec><sec id="s2_1_22"><title>2.1.22. 4-(2-(4-Bromophenyl)-1H-indol-3-yl)-3-methyl-5-(4-nitrophenyl)-1-phenyl-1,5-dihydro- 6H-pyrazolo[3,4-d]pyrimidine-6-thione 31</title><p>A mixture of compound 28 (4.56 g, 0.01 mol), N-(4-nitrophenyl)thiourea (1.97 g, 0.01 mol) and potassium hydroxide (0.5 g) in ethanol (20 ml) was refluxed with stirring for 4 h. The reaction mixture was left overnight and then concentrated under reduced pressure. The solid residue was collected, washed with water and recrystallized from ethanol to gives 31 as orange powder, Yield (3.48 g, 55%); m.p.: 150-152˚C. Anal. calcd. for C<sub>32</sub>H<sub>21</sub>BrN<sub>6</sub>O<sub>2</sub>S (633.52): C, 60.67; H, 3.34; Br, 12.61; N, 13.27; S, 5.06. Found: 60.47; H, 3.14; Br, 12.41; N, 13.07; S, 4.89.</p></sec></sec><sec id="s2_2"><title>2.2. Antimicrobial Assays</title><p>Synthesized compounds 5c, 7, 9, 11, 13a, 27, 30 and 31 were screened for their antimicrobial activitiesin vitro against two species of Gram-positive bacteria, namely Staphylococcus saureus RCMB 0100010 (SA), Bacillus subtilis RCMB 010067 (BS) and two negative bacteria, namely Pseudomonas aeuroginosa RCMB 010043 (PA), Escherichia coli CMB 010052 (EC). Two fungal strains Aspergillus fumigatus RCMB 02568 (AF) and Candida albicans RCMB 05036 (CA) are used for antifungal activity. The antibacterial and antifungal activities were determined by means of inhibition% &#177; standard deviation at a concentration of 100 μg/ml of tested samples [<xref ref-type="bibr" rid="scirp.57021-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.57021-ref16">16</xref>] . Optical densities of antimicrobial were measured after 24 hours at 37˚C to bacteria and measured after 48 hours at 28˚C to fungal using a multidetection microplate reader at the Regional Center for Mycology and Biotechnology (Sun Rise-Tecan, USA at 600 nm) Al-Azhar University. Ampicillin, gentamicin were used as bacterial standards and amphotericin B was used as fungal standards for references to evaluate the efficacy of the tested compounds under the same conditions. The MICs of the compounds assays were determined by using microbroth kinetic system [<xref ref-type="bibr" rid="scirp.57021-ref17">17</xref>] .</p></sec></sec><sec id="s3"><title>3. Results and Discussion</title><sec id="s3_1"><title>3.1. Chemistry</title><p>The synthesis of the new compounds is outlined in Schemes 1-6. 2-Substituted-indole reported to be obtained via Fischer indole synthesis using phenyl hydrazine and acetophenone derivatives 1a-d in present of polyphosphoric acid as catalysis [<xref ref-type="bibr" rid="scirp.57021-ref18">18</xref>] . Synthesis of 1H-indole-3-carboxaldehyde derivative 4 from the 2-(4-bromo- phenyl)-1H-indole 3c via Vilsmeir Haack’s formylation using phosphorus oxychloride (POCl<sub>3</sub>) and N,N<sup>/</sup>-dime- thylformamide (DMF) [<xref ref-type="bibr" rid="scirp.57021-ref19">19</xref>] (Scheme 1). The IR spectrum of 4 revealed C=O stretching band of formyl group at 1672 cm<sup>−1</sup>. 1H NMR spectrum showed an D<sub>2</sub>O-exchangeable signal at 12.40 ppm assigned to the NH proton and a non exchangeable signal at δ 9.95 ppm corresponding to the formyl proton. The mass spectrum showed the molecular ion peak at m/z 300 corresponding to the molecular formula C<sub>15</sub>H<sub>10</sub>BrNO.</p><p>The hydrazine derivatives 5a-c were obtained by the reaction of 1H-indole-3-carboxaldehyde derivative 4 with different substituted hydrazines [<xref ref-type="bibr" rid="scirp.57021-ref20">20</xref>] namely, hydrazine hydrate, phenyl hydrazine and 2-hydrazinyl-1,3- benzothiazole (Scheme 1). The molecular structure of the synthesis compounds were established based on analytical and spectral data. For example, 1H NMR spectrum of compound 5c showed an D<sub>2</sub>O -exchangeable signal at 7.95 and 11.82 assigned to the two NH protons and a non exchangeable signal at 8.42 ppm corresponding =CH proton. On other hand mass spectrum of 5c showed a molecular ion peak m/z at 447 corresponding to the molecular formula C<sub>22</sub>H<sub>15</sub>BrN<sub>4</sub>S.</p><p>Reaction of 1H-indole-3-carboxaldehyde derivative 4 with different substituted acid hydrazides [<xref ref-type="bibr" rid="scirp.57021-ref21">21</xref>] such as 2-(quinolin-8-yloxy)acetohydrazide 6a, 2-(1H-indol-3-yl)acetohydrazide 6b, 4-(1H-indol-3-yl)butanehydrazide 6c and 1-benzofuran-2-carbohydrazide 6d in presence of catalytic amount of acetic acid in absolute ethanol</p><disp-formula id="scirp.57021-formula935"><graphic  xlink:href="http://html.scirp.org/file/5-1020373x5.png"  xlink:type="simple"/></disp-formula><p>Scheme 1. Synthesis of compounds 3-5.</p><disp-formula id="scirp.57021-formula936"><graphic  xlink:href="http://html.scirp.org/file/5-1020373x6.png"  xlink:type="simple"/></disp-formula><p>Scheme 2. Synthesis of compounds 7-10.</p><disp-formula id="scirp.57021-formula937"><graphic  xlink:href="http://html.scirp.org/file/5-1020373x7.png"  xlink:type="simple"/></disp-formula><p>Scheme 3. Synthesis of compounds 11-17.</p><p>afforded the corresponding the acid hydrazide derivatives 7-10 respectively (Scheme 2). The assignment of the structure of the synthesis compounds were based on analytical and spectroscopic data. For example IR spectrum of 8 exhibit absorption band at 1604 cm<sup>−1</sup> and 1654 cm<sup>−1</sup> due to -C=N and CO groups. 1H NMR of 8 exhibits signal at δ 8.90 ppm for =CH proton and D<sub>2</sub>O-exchangeable signal at δ 4.31 and 12.03 ppm assigned to the 2NH protons. The mass spectrum of compound 8 showed the molecular ion peak at m/z 471 corresponding to the molecular formula C<sub>25</sub>H<sub>19</sub>BrN<sub>4</sub>O.</p><p>Reaction 1H-indole-3-carboxaldehyde 4 with cyanoacetohydrazide in absolute ethanol [<xref ref-type="bibr" rid="scirp.57021-ref22">22</xref>] to form the N'- [1H-indol-3-ylmethylene]-2-cyanoacetohydrazide derivative 11. The assignment of the structure of compound</p><disp-formula id="scirp.57021-formula938"><graphic  xlink:href="http://html.scirp.org/file/5-1020373x8.png"  xlink:type="simple"/></disp-formula><p>Scheme 4. Synthesis of compounds 18-23.</p><p>11 was based on analytical and spectroscopic data. Thus, the 1H NMR showed a singlet at δ 4.33 for the CH<sub>2</sub> group, a singlet at δ 8.33ppm for the =CH proton and D<sub>2</sub>O-exchangeable single at δ 11.33, 11.93 ppm for the two NH protons. <sup>13</sup>C NMR spectrum of 11 displayed signals at δ 24.39, 116.19, 157.73 and 163.58 ppm for CH<sub>2,</sub> CN, C=N and CO respectively. Further structure elucidation of compound 11 was obtained through the study of its reactivity towards chemical reagents. Thus, the reaction of 11 with 4-methylbenzene diazonium chloride [<xref ref-type="bibr" rid="scirp.57021-ref23">23</xref>] gave the hydrazone derivatives 12 (Scheme 3). The structures of the compound 12 were determined from spectroscopic and elemental analytical data (see Experimental section).</p><p>Knoevengel condensation of the 2-cyanoacetohydrazide derivatives 11 with aromatic aldehydes namely 1,3-diphenyl-1H-pyrazole-4-carboxaldehyde and p-nitrobenzaldehyde [<xref ref-type="bibr" rid="scirp.57021-ref24">24</xref>] afforded benzylidene derivatives 13a, b (Scheme 3). The IR spectrum of compound 13a, taken as a typical example of the series prepared, revealed absorption bands at 1686 cm<sup>−1</sup>, 2204 cm<sup>−1</sup>, 3335 cm<sup>−1</sup> and 3126 cm<sup>−1</sup> corresponding to carbonyl, nitrile and 2 NH groups, respectively. Where the 1H NMR spectra showed the absence of the active methylene proton and showed signals at δ 9.21 ppm for N=CH proton and D<sub>2</sub>O-exchangeable signal at δ 11.73 and 12.04 assigned to the 2NH protons. Its mass spectrum showed a molecular ion peak at m/z 611 corresponding to the molecular formula C<sub>34</sub>H<sub>23</sub>BrN<sub>6</sub>O.</p><p>Cyclocondensation of 2-cyanoacetohydrazide derivatives 11 with salicyaldehyde in dioxane in the presence of</p><disp-formula id="scirp.57021-formula939"><graphic  xlink:href="http://html.scirp.org/file/5-1020373x9.png"  xlink:type="simple"/></disp-formula><p>Scheme 5. Synthesis of compounds 25-27.</p><disp-formula id="scirp.57021-formula940"><graphic  xlink:href="http://html.scirp.org/file/5-1020373x10.png"  xlink:type="simple"/></disp-formula><p>Scheme 6. Synthesis of compounds 28-31.</p><p>a catalytic amount of piperidine afforded 2-imino-2H-chromene-3-carbohydrazide 14. The plausible mechanism for the formation of compound 14 may be attributed to the initial Knoevenagel condensation of the active methylene nitrile of 11 with carbonyl group of salicyaldehyde followed by an intramolecular 1,6-dipolar cyclization via the addition of the phenolic OH group to the cyano function to afford the target compounds [<xref ref-type="bibr" rid="scirp.57021-ref25">25</xref>] (<xref ref-type="fig" rid="fig1">Figure 1</xref>). 1H NMR spectrum of 14 showed three D<sub>2</sub>O-exchangeable signal at δ 11.44, δ 11.56 and δ 12.14 ppm due to three NH protons. Its mass spectrum showed a molecular ion peak at m/z 485 corresponding to the molecular formula C<sub>25</sub>H<sub>17</sub>BrN<sub>4</sub>O<sub>2. </sub></p><p>The reaction of 11 with ethyl cyanoacetate and elemental sulfur in the presence of triethylamine gave the thiophene derivatives [<xref ref-type="bibr" rid="scirp.57021-ref26">26</xref>] 15. The structure of compound 15 was confirmed by its infrared spectrum which indicated the absence of CN absorption band and contain the characteristic absorption bands for NH and CO func-</p><p>tional groups. On the other hand the reaction of 11 with elemental sulfur and phenylisothiocyanate [<xref ref-type="bibr" rid="scirp.57021-ref27">27</xref>] gave the thiazole derivative 16. Compounds 15 and 16 were obtained according to the proposed following mechanism (<xref ref-type="fig" rid="fig2">Figure 2</xref>). The structure of compounds 15 and 16 were elucidated on the basis of elemental analysis and spec- tral data. The IR spectrum of thiazoline 16 revealed the absence of CN absorption band and the presence of new absorption bands at 3395, 3269 cm<sup>−1</sup> assignable to NH<sub>2</sub> group and band at 1237 cm<sup>−1</sup> due to C=S group. The <sup>13</sup>C NMR data showed signals at δ 183.91, δ 161.36, δ 153 and δ 147.39 ppm to CS, CO, C-NH<sub>2</sub> and C=N. Cyclization of thiazoline 16 with acetic anhydride afforded 1,3-thiazolo[4,5-d]pyrimidin-7(6H)-one derivative 17 (Scheme 3).</p><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> Proposed mechanism of formation of compound 14</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-1020373x11.png"/></fig><fig id="fig2"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref></label><caption><title> Proposed mechanism of formation of compounds 15 and 16</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-1020373x12.png"/></fig><p>N-[1H-indol-3-ylmethylene]-1,3-thiazol-2-amine 18 was synthesized by the one-pot three compounds. Thus, condensation of phenacyl bromide, 1H-indole-3-carboxaldehyde 4 and thiourea [<xref ref-type="bibr" rid="scirp.57021-ref28">28</xref>] under conventional heating in absolute ethanol using catalytic amount of acetic acid. The 1H NMR spectra of compound 18 showed the absence of the aldehyde proton, moreover D<sub>2</sub>O-exchangeable signal at δ 12.43 ppm due to the NH proton and signal at δ 6.85 ppm for =CH proton. Condensation of 1H-indole-3-carboxaldehyde 4 with 3-acetyl-2H-chromen- 2-one [<xref ref-type="bibr" rid="scirp.57021-ref29">29</xref>] afforded 3-[3-(1H-indol-3-yl)prop-2-enoyl]-2H-chromen-2-one 19 (Scheme 4).</p><p>Condensation of 4 with cyanoacetamide, ethyl cyanoacetate and 1H-benzimidazol-2-yl-acetonitrile [<xref ref-type="bibr" rid="scirp.57021-ref30">30</xref>] afforded 3-(1H-indol-3-yl)-2-cyanoprop-2-enamide, ethyl 3-(1H-indol-3-yl)-2-cyanoprop-2-enoate 20a,b and 2- (1H-benzimidazol-2-yl)-3-(1H-indol-3-yl)crylonitrile 22 respectively (Scheme 4). The structure of the reaction product 20a,b and 22 were ascertained on the basis of its elemental analysis and spectral data. The IR spectrum of compound 20a exhibited characteristic absorption bands at 3466 cm<sup>−1</sup>, 3310 cm<sup>−1</sup>, 2203 cm<sup>−1</sup> and 1688 cm<sup>−1</sup> corresponding to NH<sub>2</sub>, CN and CO groups respectively. The 1H NMR spectrum of 20a indicated the presence of one singlet peak at δ 8.22 ppm of the =CH proton and the disappearance of a singlet at δ 9.95 ppm of CHO proton. Cyclization of 20b by hydrazine hydrate to 5-oxopyrazolidine-4-carbonitrile derivative 21 was achieved by refluxing in ethanol. The 1H NMR spectrum of compound 21 indicated the presence of D<sub>2</sub>O-ex- changeable singlet at δ 10.18, δ 11.41 and δ 12.22 ppm which correspond to three NH groups.</p><p>On the other hand, the reaction of 1H-indole-3-carboxaldehyde 4 with rhodanine-3-acetic acid [<xref ref-type="bibr" rid="scirp.57021-ref31">31</xref>] afforded [5-(1H-indol-3-ylmethylene)-1,3-thiazolidin-3-yl]acetic acid derivative 23. The 1H-NMR spectrum of compound 23 indicated the presence of singlet at δ 4.71 ppm of the CH<sub>2</sub> and D<sub>2</sub>O-exchangeable singlet at δ 12.60 ppm of the OH proton. Mass spectrum of 23 showed a molecular ion peak m/z at 473 corresponding to the molecular formula C<sub>20</sub>H<sub>13</sub>BrN<sub>2</sub>O<sub>3</sub>S<sub>2</sub> (Scheme 4).</p><p>The key substrate ester 25 was synthesized from the reaction of 4-phenyl-2-amino-thiazole 24 and diethyl malonate. Reaction of ester 25 with thiourea in ethanolic sodium ethoxide solution afforded 6-[1,3-thiazol- 2-ylamino]-2-thioxo-2,3-dihydropyrimidin-4(5H)-one derivative [<xref ref-type="bibr" rid="scirp.57021-ref32">32</xref>] 26. Treatment of pyrimidinone derivative 26 with 1H-indole-3-carboxaldehyde 4 afforded 5-[1H-indol-3-ylmethylene]-2-thioxo-2,5-dihydropyrimidin- 4(3H)-one 27 (Scheme 5). The structure of 27 was identified as the reaction product on the basis of its elemental analysis and spectroscopic data. The 1H NMR spectrum of compound 27 indicated the presence of singlet signal at δ 9.96 ppm of the =CH proton and D<sub>2</sub>O-exchangeable singlet at δ 12.18, δ 12.22 and δ 12.40 ppm corresponding to the three NH protons.<sup>13</sup>C NMR spectrum showed signal at δ 185.37 (C=S) and 168.01 (C=O).</p><p>Condensation of 1H-indole-3-carboxaldehyde 4 with 5-methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one afforded 4-[1H-indol-3-ylmethylene]-1H-pyrazol-5(4H)one 28 (Scheme 6). The IR spectrum of 28 exhibited characteristic absorption bands at 3275 cm<sup>−1</sup> and 1706 cm<sup>−1</sup> corresponding to NH and CO groups, respectively.<sup>13</sup>C NMR spectrum showed signal at δ 12.58 (CH<sub>3</sub>), δ 153 (C=C) and δ 160 (C=O). Mass spectrum of 28 showed a molecular ion peak m/z at 456 corresponding to the molecular formula C<sub>25</sub>H<sub>18</sub>BrN<sub>3</sub>O.</p><p>Compound 28 was used as key intermediates in the synthesis of novel pyrazolo[3,4-c]pyrazolone and pyrazole[3.4-d] pyrimidine derivatives via their interaction with different reagents. Thus, the reaction of 28 with hydrazine hydrate, phenyl hydrazine and N-(4-methylphenyl)thiosemicarbazide by cyclocondensation reaction [<xref ref-type="bibr" rid="scirp.57021-ref33">33</xref>] afforded 3-(4-methyl-pyrazolo[3,4-c]pyrazol-3-yl)-1H-indole derivatives 29a,b and pyrazolo[3,4-c]-pyrazole- 2(6H)-carbothioamide 30 respectively (Scheme 6). The structure of the newly synthesis compounds were based on their correct elemental analysis and spectral data. 1H NMR spectrum of 30 exhibited a singlet signal at δ 2.28 ppm due to CH<sub>3</sub> protons of tolyl moiety. Its mass spectrum, the compound displayed the molecular ion peak at m/z 617 corresponding to the molecular formula C<sub>33</sub>H<sub>25</sub>BrN<sub>6</sub>S. Alternatively, treatment of the compound 28 with N-(4-nitrophenyl)thiourea [<xref ref-type="bibr" rid="scirp.57021-ref34">34</xref>] afforded pyrazolo[3,4-d]pyrimidine-6-thione derivatives 31. The structures of the compound 31 were determined from spectroscopic and elemental analytical data (see Experimental section).</p></sec><sec id="s3_2"><title>3.2. Antimicrobial Activity</title><p>The newly synthesized compounds 5c, 7, 9, 11, 13a, 27, 30 and 31 were evaluated for their in vitro antibacterial activity against Gram-positive namely Staphylococcus aureus RCMB 0100010 (SA) and Bacillus subtilis RCMB 010067 (BS) and Gram-negative Pseudomonas aeuroginosa RCMB 010043 (PA) and Escherichia coli RCMB 010052 (EC). They were also evaluated for their in vitro antifungal activity against Aspergillus fumigatus RCMB 02568 (AF) and Candida albicans RCMB 05036 (CA). Ampicillin was the standard used for the evaluation of antibacterial activity against gram positive bacteria and Gentamicin was used as a standard in assessing the activity of the tested compounds against gram negative bacteria, while Amphotericin B was taken as a reference for the antifungal effect. The inhibitory effects of the synthetic compounds against these organisms are given in <xref ref-type="table" rid="table2">Table 2</xref>, <xref ref-type="fig" rid="fig3">Figure 3</xref> and <xref ref-type="fig" rid="fig4">Figure 4</xref>.</p><p>In general, most of the tested compounds revealed better activity against the Gram-positive rather than the Gram-negative bacteria. All test compounds were found to be inactive against Pseudomonas aeuroginosa RCMB 010043 (PA). It was shown (<xref ref-type="fig" rid="fig3">Figure 3</xref>) that the majority of the compounds studied possessed significant antibacterial activity towards Staphylococcus aureus RCMB 0100010 (SA), Bacillus subtilis RCMB 010067 (BS) and Escherichia coli RCMB 010052 (EC). The highest activities were observed for compounds 9 and 30, followed by 11, 13a and 31.Compounds 5c, 7 and 27 showed the least antibacterial activity.</p><p>It was shown (<xref ref-type="fig" rid="fig4">Figure 4</xref>) that the compounds 5c, 11, 31 strong antifunger activity against Aspergillus fumigates RCMB 02568 (AF) and Candida albicans RCMB 05036 (CA) comparable to Amphotericin B. The com-</p><fig id="fig3"  position="float"><label><xref ref-type="fig" rid="fig3">Figure 3</xref></label><caption><title> Graphical representation of the antibacterial activity of tested compounds compared to Ampicillin and Gentamicin</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-1020373x13.png"/></fig><fig id="fig4"  position="float"><label><xref ref-type="fig" rid="fig4">Figure 4</xref></label><caption><title> Graphical representation of the antifungal activity of tested compounds compared to Amphotericin B</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-1020373x14.png"/></fig><p>pounds 9, 13a and 30 showed moderate activities against Aspergillus fumigates RCMB 02568 (AF) and Candida albicans RCMB 05036 (CA) comparable to Amphotericin B. While the compounds 7 and 27 weak antifungal activity against Aspergillus fumigates RCMB 02568 (AF) and Candida albicans RCMB 05036 (CA) comparable to Amphotericin B.</p><p>The minimum inhibitory concentration (MIC) was considered to be the lowest concentration of the tested compound which inhibits growth of the microorganisms. The initial screening of the tested compounds showed promising activity of the compounds 5c, 9, 30 and 31 which encouraged the determination of their minimum inhibitory concentration (MIC) (<xref ref-type="table" rid="table3">Table 3</xref>).</p><p>The best results were demonstrated by compounds 9, 30 and 31 as antibacteria, it possessed double the activity of the standard, Ampicillin against Bacillus subtilis RCMB 010067 (BS) 1.95 and 3.9 μg/ml respectively. Moderate activity against Staphylococcus aureus RCMB 0100010 (SA) and Escherichia coli RCMB 010052 (EC) were also demonstrated by compounds 9 and 30. On other hand moderate activity against Aspergillus fumigatus RCMB 02568 (AF) and Candida albicans RCMB 05036 (CA) were also demonstrated by compounds 5c and 31.</p><table-wrap-group id="2"><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Antimicrobial evaluation of the some synthesized compounds</title></caption><table-wrap id="2_1"><caption><title>: Staphylococcus aureus RCMB 0100010, (BS)</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="3"  >Comp. No.</th><th align="center" valign="middle"  colspan="4"  >Inhibition % &#177; standard deviation</th><th align="center" valign="middle"  colspan="2"  ></th></tr></thead><tr><td align="center" valign="middle"  colspan="2"  >Gram positive bacteria</td><td align="center" valign="middle"  colspan="2"  >Ggram negative e bacteria</td><td align="center" valign="middle" >Fungal</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >SA</td><td align="center" valign="middle" >BS</td><td align="center" valign="middle" >PA</td><td align="center" valign="middle" >ES</td><td align="center" valign="middle" >AF</td><td align="center" valign="middle" >CA</td></tr><tr><td align="center" valign="middle" >5c</td><td align="center" valign="middle" >56.85 &#177; 0.58</td><td align="center" valign="middle" >68.32 &#177; 1.2</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >46.32 &#177; 0.58</td><td align="center" valign="middle" >89.25 &#177; 0.72</td><td align="center" valign="middle" >80.23 &#177; 1.2</td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >21.25 &#177; 0.58</td><td align="center" valign="middle" >25.63 &#177; 0.28</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >14.63 &#177; 0.2</td><td align="center" valign="middle" >11.22 &#177; 0.28</td><td align="center" valign="middle" >9.32 &#177; 0.72</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >82.63 &#177; 0.75</td><td align="center" valign="middle" >90.42 &#177; 0.28</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >72.46 &#177; 0.28</td><td align="center" valign="middle" >64.35 &#177; 0.58</td><td align="center" valign="middle" >52.14 &#177; 0.63</td></tr><tr><td align="center" valign="middle" >11</td><td align="center" valign="middle" >76.8 &#177; 0.58</td><td align="center" valign="middle" >89.4 &#177; 0.63</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >63.5 &#177; 0.72</td><td align="center" valign="middle" >90.3 &#177; 0.58</td><td align="center" valign="middle" >83.6 &#177; 0.28</td></tr><tr><td align="center" valign="middle" >13a</td><td align="center" valign="middle" >72.14 &#177; 0.58</td><td align="center" valign="middle" >81.32 &#177; 0.63</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >64.21 &#177; 0.63</td><td align="center" valign="middle" >52.63 &#177; 0.58</td><td align="center" valign="middle" >42.18 &#177; 1.2</td></tr><tr><td align="center" valign="middle" >27</td><td align="center" valign="middle" >32.6 &#177; 0.63</td><td align="center" valign="middle" >40.4 &#177; 0.85</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >23.6 &#177; 1.2</td><td align="center" valign="middle" >20.3 &#177; 1.2</td><td align="center" valign="middle" >15.4 &#177; 0.58</td></tr><tr><td align="center" valign="middle" >30</td><td align="center" valign="middle" >90.3 &#177; 1.2</td><td align="center" valign="middle" >92.4 &#177; 0.72</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >71.6 &#177; 0.93</td><td align="center" valign="middle" >72.4 &#177; 0.58</td><td align="center" valign="middle" >62.5 &#177; 0.28</td></tr><tr><td align="center" valign="middle" >31</td><td align="center" valign="middle" >76.8 &#177; 0.58</td><td align="center" valign="middle" >89.4 &#177; 0.63</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >63.5 &#177; 0.72</td><td align="center" valign="middle" >90.3 &#177; 0.58</td><td align="center" valign="middle" >83.6 &#177; 0.28</td></tr><tr><td align="center" valign="middle" >Ampicillin</td><td align="center" valign="middle" >96.52 &#177; 0.2</td><td align="center" valign="middle" >99.65 &#177; 0.3</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Gentamicin</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >89.23 &#177; 0.1</td><td align="center" valign="middle" >82.14 &#177; 0.3</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Amphotericin B</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >96.25 &#177; 0.1</td><td align="center" valign="middle" >91.29 &#177; 0.1</td></tr></tbody></table></table-wrap></table-wrap-group><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Minimum inhibitory concentration of compounds 5c, 9, 29 and 31</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="3"  >Comp. No.</th><th align="center" valign="middle"  colspan="4"  >Minimum inhibitory concentration (&#181;g/ml)</th><th align="center" valign="middle"  colspan="2"  ></th></tr></thead><tr><td align="center" valign="middle"  colspan="2"  >Gram positive bacteria</td><td align="center" valign="middle"  colspan="2"  >Gram negative e bacteria</td><td align="center" valign="middle" >Fungi</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >SA</td><td align="center" valign="middle" >BS</td><td align="center" valign="middle" >PA</td><td align="center" valign="middle" >EC</td><td align="center" valign="middle" >AF</td><td align="center" valign="middle" >CA</td></tr><tr><td align="center" valign="middle" >5c</td><td align="center" valign="middle" >31.25</td><td align="center" valign="middle" >15.63</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >62.5</td><td align="center" valign="middle" >3.9</td><td align="center" valign="middle" >3.9</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >3.9</td><td align="center" valign="middle" >1.95</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >7.81</td><td align="center" valign="middle" >15.63</td><td align="center" valign="middle" >31.25</td></tr><tr><td align="center" valign="middle" >30</td><td align="center" valign="middle" >1.95</td><td align="center" valign="middle" >1.95</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >7.81</td><td align="center" valign="middle" >7.81</td><td align="center" valign="middle" >15.63</td></tr><tr><td align="center" valign="middle" >31</td><td align="center" valign="middle" >7.81</td><td align="center" valign="middle" >1.95</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >15.63</td><td align="center" valign="middle" >1.95</td><td align="center" valign="middle" >3.9</td></tr><tr><td align="center" valign="middle" >Ampicillin</td><td align="center" valign="middle" >0.98</td><td align="center" valign="middle" >3.9</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Gentamicin</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >1.95</td><td align="center" valign="middle" >3.9</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Amphotericin B</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.98</td><td align="center" valign="middle" >1.95</td></tr></tbody></table></table-wrap></sec></sec><sec id="s4"><title>4. Conclusion</title><p>In the present work, we synthesized novel series of 3-substituted indole by reaction of indole-3-carboxaldehyde derivative with different reagents. Screening for some selected compounds was carried for their potential antibacterial, antifungal activity. Most of the tested compounds revealed better activity against the Gram-positive rather than the Gram negative bacteria. All test compounds were found to be inactive against Pseudomonas aeuroginosa. Compounds 9, 30 and 31 exhibited excellent activity against Staphylococcus aureus, Bacillus subtilis and Escherichia coli compared with the standards drugs, while compounds 5c, 11 and 31 have strong antifunger activity against Aspergillus fumigatus and Candida albicans comparable to Amphotericin B.</p></sec></body><back><ref-list><title>References</title><ref id="scirp.57021-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Nagai, K., Davies, T.A., Jacobs, M.R. and Appelbaum, P.C. (2002) Effects of Amino Acid Alterations in Penicillin-Binding Proteins (Pbps) 1a, 2b, and 2× on PBP Affinities of Penicillin, Ampicillin, Amoxicillin, Cefditoren, Cefuroxime, Cefprozil, and Cefaclor in 18 Clinical Isolates of Penicillin-Susceptible, Intermediate, and Resistant Pneumococci. Antimicrobial Agents and Chemotherapy, 46, 1273-1280. http://dx.doi.org/10.1128/AAC.46.5.1273-1280.2002</mixed-citation></ref><ref id="scirp.57021-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Kaniwa, K., Arai, M.A., Li, X. and Ishibashi, M. (2007) Synthesis, Determination of Stereochemistry, and Evaluation of New Bisindole Alkaloids from the Myxomycete Arcyriaferruginea: An Approach for Wnt Signal Inhibitor. Bioorganic &amp; Medicinal Chemistry Letters, 17, 4254-4257. http://dx.doi.org/10.1016/j.bmcl.2007.05.033</mixed-citation></ref><ref id="scirp.57021-ref3"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mingxing Teng</surname><given-names> M. </given-names></name>,<etal>et al</etal>. (<year>2014</year>)<article-title>Total Synthesis of the Monoterpenoid Indole Alkaloid (±)-Aspidophylline A</article-title><source> Angewandte Chemie International Edition</source><volume> 53</volume>,<fpage> 1814</fpage>-<lpage>1817</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.57021-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Pilar, M.F., Pedro, M. and Juan, A.B. (2001) Synthesis of the Indole Alkaloids Meridianins from the Tunicate Aplidium Meridianum. Tetrahedron, 57, 2355-2363. http://dx.doi.org/10.1016/S0040-4020(01)00102-8</mixed-citation></ref><ref id="scirp.57021-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Sharma, A. and Pathak, D.M. (2013) The Synthesis and Antimicrobial Activity of Indole Thiacarbamide Derivatives. International Journal of Scientific &amp; Engineering Research, 4, 203-206.</mixed-citation></ref><ref id="scirp.57021-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Chavan Rajashree, S. and More Harinath, N. (2011) Synthesis, Characterization and Evaluation of Analgesic and Anti- Inflammatory Activities of Some Novel 2-(4,5-Dihydro-1H-pyrazol-3-yl)-3-phenyl-1H-indole. Journal of Pharmacy Research, 4, 1575-1578.</mixed-citation></ref><ref id="scirp.57021-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Kawasaki, I., Katsuma, H., Nakayama, Y., Yamashita, M.Y. and Ohta, S. (1998) Total Synthesis of Topsentin, Antiviral and Antitumor Bis(indolyl)imidazole. Heterocycles, 48, 1887-1901. http://dx.doi.org/10.3987/COM-98-8225</mixed-citation></ref><ref id="scirp.57021-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Kawasaki, I., Yamashita, M.Y. and Ohta, S. (1996) Total Synthesis of Nortopsentins A-D, Marine Alkaloids. Chemical and Pharmaceutical Bulletin, 44, 1831-1839. http://dx.doi.org/10.1248/cpb.44.1831</mixed-citation></ref><ref id="scirp.57021-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Sun, H.H. and Sakemi, J. (1991) A Brominated (Aminoimidazolinyl)indole from the Sponge Discodermia Polydiscus. The Journal of Organic Chemistry, 56, 4307-4308. http://dx.doi.org/10.1021/jo00013a045</mixed-citation></ref><ref id="scirp.57021-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Raju, R., Gromyko, O., Fedorenko, V., Luzhetskyy, A. and Müler, R. (2012) Pimprinols A-C, from the Terrestrial Actinomycete, Streptomyces sp. Tetrahedron Letters, 53, 3009-3011. http://dx.doi.org/10.1016/j.tetlet.2012.03.134</mixed-citation></ref><ref id="scirp.57021-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Fresneda, P.M., Castaneda, M., Blug, M. and Molina, P. (2007) Iminophosphorane-Based Preparation of 2,5-Disub- stituted Oxazole Derivatives: Synthesis of the Marine Aalkaloid Almazole C. Synlett, 2, 324-326.http://dx.doi.org/10.1055/s-2007-967995</mixed-citation></ref><ref id="scirp.57021-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Aaron, M.S., Richard, A.L. and David, C.R. (2007) Bacillamides from a Hypersaline Microbial Mat Bacterium. Journal of Natural Products, 70, 1793-1795. http://dx.doi.org/10.1021/np070126a</mixed-citation></ref><ref id="scirp.57021-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Gao, X., Chooi, Y.-H., Ames, B.D., Wang, P., Walsh, C.T. and Tang,Y. (2011) Fungal Indole Alkaloid Biosynthesis: Genetic and Biochemical Investigation of the Tryptoquialanine Pathway in Penicillium aethiopicum. Journal of the American Chemical Society, 133, 2729-2741. http://dx.doi.org/10.1021/ja1101085</mixed-citation></ref><ref id="scirp.57021-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Mohamed, A.R. and Mahmound, E.S. (2007) Synthesis and Antitumor Activity of Indolylpyrimidines: Marine Natural Product Meridianin D Analogues. Bioorganic &amp; Medicinal Chemistry Letters, 15, 1206-1217.http://dx.doi.org/10.1016/j.bmc.2006.11.023</mixed-citation></ref><ref id="scirp.57021-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Sofy, A.R., Hmed, A.A., Sharaf, A.M. and El-Dougdoug, K.A. (2014) Structural Changes of Pathogenic Multiple Drug Resistance Bacteria Treated With T. Vulgaris Aqueous Extract. Nature and Science, 12, 83-88.</mixed-citation></ref><ref id="scirp.57021-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Caldeira, E.M., Osório, A., Oberosler, E.L., Vaitsman, D.S., Alviano, D.S. and Nojima, M.D.G. (2013) Antimicrobial and Fluoride Release Capacity of Orthodontic Bonding Materials. Journal of Applied Oral Science, 21, 327-334.http://dx.doi.org/10.1590/1678-775720130010</mixed-citation></ref><ref id="scirp.57021-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Kaya, E.G., Ozbilge, H. and Albayrak, S. (2009) Determination of the Effect of Gentamicin against Staphlococcus aureus by Using Microbroth Kinetic System. ANKEM Dergisi, 23,110-114.</mixed-citation></ref><ref id="scirp.57021-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">March, S.J. (2000) Advanced Organic Chemistry: Reactions, Mechanisms and Structure. 5th Edition, John Wiley and Sons, New York, 1824.</mixed-citation></ref><ref id="scirp.57021-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Attaryan, O., Antanosyan, S., Panosyan, G., Asratyan, G. and Matsoyan, S. (2006) Vilsmeier Formyatiom of 3,5-Di-methylpyrazoles. Russian Journal of General Chemistry, 76, 1817-1819.http://dx.doi.org/10.1134/S1070363206110260</mixed-citation></ref><ref id="scirp.57021-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">El-Nakkady, S.S., Hanna, M.M., Roaiah, H.M. and Ghannam, I.A. (2012) Synthesis, Molecular Docking Study and Antitumor Activity of Novel 2-Phenylindole Derivatives. European Journal of Medicinal Chemistry, 47, 387-398.http://dx.doi.org/10.1016/j.ejmech.2011.11.007</mixed-citation></ref><ref id="scirp.57021-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Saundane, A.R., Katkar, V.T. and Vaijinath, V. (2013) Synthesis, Antimicrobial, and Antioxidant Activities of N-[(5'- Substitut-ed-2'-phenyl-1H-indol-3-yl)methylene]-5H-dibenzo[b,f]azepine-5-carbohydrazide Derivatives. Journal of Chemistry, 2013, 1- 9. http://dx.doi.org/10.1155/2013/530135</mixed-citation></ref><ref id="scirp.57021-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Mahmouda, M.R., El-Ziatya, A.K., Abu El-Azma, F.S.M., Ismail, M.F. and Shibab, S.A. (2013) Utility of Cyano-N- (2-oxo-1,2-dihydroindol-3-ylidene)acetohydrazide in the Synthesis of Novel Heterocycles. Journal of Chemical Research, 37, 80-85. http://dx.doi.org/10.3184/174751912X13567100793191</mixed-citation></ref><ref id="scirp.57021-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Mohareb, R.M., El-Arab, E.E. and El-Sharkawy, K.A. (2009) The Reaction of Cyanoacetic Acid Hydrazide with 2-Acetylfuran: Synthesis of Coumarin, Pyridine, Thiophene and Tthiazole Derivatives with Potential Antimicrobial Activities. Scientia Pharmaceutica, 77; 355-366. http://dx.doi.org/10.3797/scipharm.0901-20</mixed-citation></ref><ref id="scirp.57021-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Darwish, E.S., Abdel Fattah, A.M., Attaby, F.A. and Al-Shayea, O.N. (2014) Synthesis and Antimicrobial Evaluation of Some Novel Thiazole, Pyridone, Pyrazole, Chromene, Hydrazone Derivatives Bearing a Biologically Active Sulfonamide Moiety. International Journal of Molecular Sciences, 15, 1237-1254. http://dx.doi.org/10.3390/ijms15011237</mixed-citation></ref><ref id="scirp.57021-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Volmajer, J., Toplak, R., Leban, I. and Le Marechal, A.M. (2005) Synthesis of New Iminocoumarins and Their Transformations into N-Chloro and Hydrazono Compounds. Tetrahedron, 61, 7012-7021.http://dx.doi.org/10.1016/j.tet.2005.05.020</mixed-citation></ref><ref id="scirp.57021-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Alafeefy, A.M., Alqasoumi, S.I., Ashour, A.E., Masand, V., Al-Jaber, N.A., Hadda, T.B. and Mohamed, M.A. (2012) Quinazoline-Tyrphostin as a New Class of Antitumor Agents, Mo-lecular Properties Prediction, Synthesis and Biological Testing. European Journal of Medicinal Chemistry, 53, 133-140. http://dx.doi.org/10.1016/j.ejmech.2012.03.044</mixed-citation></ref><ref id="scirp.57021-ref27"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>El-Gaml</surname><given-names> K.M. </given-names></name>,<etal>et al</etal>. (<year>2015</year>)<article-title>Synthesis and Antimicrobial Evaluation of New Polyfunctionally Substituted Heterocyclic Compounds Derived from 2-Cyano-N-(3-cyanoquinolin-2-yl)acetamide</article-title><source> American Journal of Organic Chemistry</source><volume> 5</volume>,<fpage> 1</fpage>-<lpage> 9</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.57021-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Ravibabu, V., Janardhan, B., Rajitha, G. and Rajitha, B. (2013) Efficient One-Pot Three-Component Synthesis of Thiazolylpyrazole Derivatives under Conventional Method. Der Chemica Sinica, 4, 79-83.</mixed-citation></ref><ref id="scirp.57021-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Dilli Varaprasad, E., Mastan, M. and Sobha Rani, T. (2012) Synthesis and Evaluation of Analgesic Activity of Novel Series of Indole Derivatives Linked to Isoxazole Moiety. Der Pharmacia Lettre, 4, 1431-1437.</mixed-citation></ref><ref id="scirp.57021-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">El-Nakkady, S., Abbas, S., Roaiah, H. and Ali, I. (2012) Synthesis, Antitumor and Anti-Inflammatory Ac-tivities of 2- Thienyl-3-Substitued Indole Derivatives. Global Journal of Pharmacology, 6, 166-177.</mixed-citation></ref><ref id="scirp.57021-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Chen, Z.-H., Zheng, C.-J., Sun, L.-P. and Piao, H.-R. (2010) Synthesis of New Chalcone Derivatives Containing Rhodanine-3-Acetic Acid Moiety with Potential Anti-Bacterial Activity. European Journal of Medicinal Chemistry, 45, 5739-5743. http://dx.doi.org/10.1016/j.ejmech.2010.09.031</mixed-citation></ref><ref id="scirp.57021-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Chaudhari, S.A., Sandeep, R., Patil, S.R., Patil, V.M., Patil, S.V., Jachak, M.N. and Desai, A. (2015) Synthesis of Pyrano[2,3-d]pyridine, Pyrazolo[3,4-b]pyridine Derivatives by Microwave Irradiation and Study of Their Insecticidal Activity. Journal of Chemical and Pharmaceutical Research, 9,476-482.</mixed-citation></ref><ref id="scirp.57021-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Shabaan, M., Taher, A.T. and Osma, E.O. (2011) Synthesis of Novel 3,4-Dihydroquinoxalin-2(1H)-one De-rivatives. European Journal of Chemistry, 2, 365-371. http://dx.doi.org/10.5155/eurjchem.2.3.365-371.289</mixed-citation></ref><ref id="scirp.57021-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Abdelhafez, O.M., Amin, K.M., Batran, R.Z., Maher, T.J., Somaia, A., Nada, S.A. and Sethumadhavan, S. (2010) Synthesis, Anticoagulant and PIVKA-II Induced by New 4-Hydroxycoumarin Derivatives. Bioorganic &amp; Medicinal Chemistry, 18, 3371-3378. http://dx.doi.org/10.1016/j.bmc.2010.04.009</mixed-citation></ref></ref-list></back></article>